{"content":"<li class=\"n-box-item date-title\" data-end=\"1525147199\" data-start=\"1525060800\" data-txt=\"Monday, December 23, 2019\">Monday, April 30, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3350547\" data-ts=\"1525130840\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MTZ\" target=\"_blank\">MTZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350547-mastecplus-4-after-q1-beat-guides-q2-full-year-eps-above-consensus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MasTec +4% after Q1 beat; guides Q2, full year EPS above consensus</a></h4><ul>     <li>MasTec (NYSE:<a href='https://seekingalpha.com/symbol/MTZ' title='MasTec, Inc.'>MTZ</a>) <font color='green'>+4%</font> after-hours as it easily beats <a href=\"https://seekingalpha.com/news/3350488-mastec-beats-0_14-beats-revenue\" target=\"_blank\">Q1 earnings</a> expectations and guides Q2 and FY 2018 earnings above consensus.</li>     <li>For Q2, MTZ sees EPS of $1.03 vs. $1.01 analyst consensus estimate and revenues of ~$1.78B vs. $1.81B consensus, with adjusted EBITDA of ~$189M; for the full year, MTZ forecasts EPS of $3.65 vs. $3.50 consensus and revenues of ~$6.9B vs. $6.77B consensus, with adjusted EBITDA of ~$700M, or 10.2% of revenue.</li>     <li>MTZ also says it 18-month backlog hit a record for the second straight quarter, with backlog as of March  31 at $7.6M, a $1.9B or 33% increase from a year ago.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3350547\" data-linked=\"MasTec +4% after Q1 beat; guides Q2, full year EPS above consensus\" data-tweet=\"$MTZ - MasTec +4% after Q1 beat; guides Q2, full year EPS above consensus https://seekingalpha.com/news/3350547-mastecplus-4-after-q1-beat-guides-q2-full-year-eps-above-consensus?source=tweet\" data-url=\"https://seekingalpha.com/news/3350547-mastecplus-4-after-q1-beat-guides-q2-full-year-eps-above-consensus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350541\" data-ts=\"1525128207\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QTNA\" target=\"_blank\">QTNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350541-quantennaplus-8_1-on-q1-beat-forecast-for-record-revenues\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Quantenna +8.1% on Q1 beat, forecast for record revenues</a></h4><ul>   <li>Quantenna Communications (NASDAQ:<a href='https://seekingalpha.com/symbol/QTNA' title='Quantenna Communications'>QTNA</a>) is <font color='green'>up 8.1%</font> after hours following a beat on top and bottom lines and expectations for Q2 record revenues in its <a href=\"https://seekingalpha.com/news/3350427-quantenna-communications-beats-0_02-beats-revenue\" target=\"_blank\">Q1 earnings report</a>.</li>    <li>Gross profit was up 22.5% to $22.77M, on revenues that grew 19.1% to $45.1M.</li>    <li>Net loss widened on a GAAP basis, to $3.25M from a year-ago loss of $884,000; non-GAAP net income dipped to $1.16M from $1.22M.</li>    <li>Cash and equivalents stood at $24.6M, vs. $24.4M as of Dec. 31.</li>    <li>For Q2, it's guiding to record revenues of $51M-$53M, non-GAAP gross margin of 48% (plus or minus 100 basis points) and EPS of $0.07-$0.09.</li>    <li><a href=\"https://seekingalpha.com/pr/17146163-quantenna-announces-first-quarter-2018-financial-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3350541\" data-linked=\"Quantenna +8.1% on Q1 beat, forecast for record revenues\" data-tweet=\"$QTNA - Quantenna +8.1% on Q1 beat, forecast for record revenues https://seekingalpha.com/news/3350541-quantennaplus-8_1-on-q1-beat-forecast-for-record-revenues?source=tweet\" data-url=\"https://seekingalpha.com/news/3350541-quantennaplus-8_1-on-q1-beat-forecast-for-record-revenues\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:43 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350540\" data-ts=\"1525127852\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CCO\" target=\"_blank\">CCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350540-clear-channel-outdoorminus-6_3-operating-income-tumbles\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Clear Channel Outdoor -6.3% as operating income tumbles</a></h4><ul>   <li>Clear Channel Outdoor Holdings (NYSE:<a href='https://seekingalpha.com/symbol/CCO' title='Clear Channel Outdoor Holdings, Inc.'>CCO</a>) is <font color='red'>6.3% lower</font> postmarket after posting <a href=\"https://seekingalpha.com/news/3350501-clear-channel-outdoor-beats-revenue\" target=\"_blank\">fiscal Q4 earnings</a> that beat revenue expecations but contained operating income down for both the quarter and the full year.</li>    <li>Revenue ticked up slightly, but fell 0.3% after adjusting for a $26.7M impact from foreign exchange and an $18.2M impact from the sale of certain businesses.</li>    <li>Revenue in the Americas fell $11M (down 3.2%); international revenues were up 17.6M (up 4.7%).</li>    <li>But operating income dropped 64.3%, to $89.6M, and OIBDAN fell 11.8%.</li>    <li><a href=\"http://www.clearchanneloutdoor.com\" target=\"_blank\">Conference call</a> to come tomorrow at 8 a.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/17146308-clear-channel-outdoor-holdings-inc-reports-results-2017-fourth-quarter-full-year\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3350540\" data-linked=\"Clear Channel Outdoor -6.3% as operating income tumbles\" data-tweet=\"$CCO - Clear Channel Outdoor -6.3% as operating income tumbles https://seekingalpha.com/news/3350540-clear-channel-outdoorminus-6_3-operating-income-tumbles?source=tweet\" data-url=\"https://seekingalpha.com/news/3350540-clear-channel-outdoorminus-6_3-operating-income-tumbles\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:37 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350534\" data-ts=\"1525125564\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RIG\" target=\"_blank\">RIG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350534-transocean-turns-lower-after-reporting-q1-loss-decline-in-revenues\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Transocean turns lower after reporting Q1 loss, decline in revenues</a></h4><ul>     <li>Transocean (NYSE:<a href='https://seekingalpha.com/symbol/RIG' title='Transocean Ltd.'>RIG</a>) <font color='red'>-2.3%</font> after-hours as it reports a larger than expected <a href=\"https://seekingalpha.com/news/3350444-transocean-misses-0_11-beats-revenue\" target=\"_blank\">Q1 loss</a> and a 15% Y/Y decline in total revenues to $684M</li>     <li>Q1 contract drilling revenues rose 5.5% Q/Q to $664M, primarily due to the addition of four harsh environment semi-submersibles when it acquired Songa Offshore, but gains were partly offset by reduced operating days on some ultra\u2011deepwater rigs that rolled off contract; results also include $38M in early termination fees on the <em>Discoverer Clear Leader</em> compared with $25M in the prior quarter.</li>     <li>Cash flows from operating activities declined to $103M from $141M in the previous quarter, also due mostly to the receipt in Q4 of the early termination payment related to the <em>Discoverer Clear Leader</em>.</li>     <li>RIG's acquisition of Songa&nbsp;Offshore during Q1 added $3.7B in contract backlog, which totaled $12.5B as of the April&nbsp;2018 fleet status report.</li></ul><div class=\"tiny-share-widget\" data-id=\"3350534\" data-linked=\"Transocean turns lower after reporting Q1 loss, decline in revenues\" data-tweet=\"$RIG - Transocean turns lower after reporting Q1 loss, decline in revenues https://seekingalpha.com/news/3350534-transocean-turns-lower-after-reporting-q1-loss-decline-in-revenues?source=tweet\" data-url=\"https://seekingalpha.com/news/3350534-transocean-turns-lower-after-reporting-q1-loss-decline-in-revenues\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350525\" data-ts=\"1525124331\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KPTI\" target=\"_blank\">KPTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350525-after-hours-gainers-losers-04-30-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers (04/30/2018)</a></h4><ul>     <li><b>Top gainers:</b>&nbsp;<a href='https://seekingalpha.com/symbol/KPTI' title='Karyopharm Therapeutics Inc.'>KPTI</a>&nbsp;<font color='green'>+22.4%</font>.&nbsp;<a href='https://seekingalpha.com/symbol/INGN' title='Inogen, Inc'>INGN</a> <font color='green'>+19.3%</font>. <a href='https://seekingalpha.com/symbol/NTRI' title='Nutrisystem Inc'>NTRI</a> <font color='green'>+13.4%</font>. <a href='https://seekingalpha.com/symbol/EFII' title='Electronics for Imaging, Inc.'>EFII</a>&nbsp;<font color='green'>+8.3%</font>. <a href='https://seekingalpha.com/symbol/QTNA' title='Quantenna Communications'>QTNA</a>&nbsp;<font color='green'>+6.1%</font>.</li><li><strong>Top Losers:</strong> <a href='https://seekingalpha.com/symbol/CGNX' title='Cognex Corporation'>CGNX</a> <font color='red'>-15.9%</font>. <a href='https://seekingalpha.com/symbol/IVAC' title='Intevac, Inc.'>IVAC</a> <font color='red'>-13.7%.&nbsp;</font><a href='https://seekingalpha.com/symbol/RIG' title='Transocean Ltd.'>RIG</a>&nbsp;<font color='red'>-2.2%.&nbsp;</font><a href='https://seekingalpha.com/symbol/FNSR' title='Finisar Corporation'>FNSR</a>&nbsp;<font color='red'>-2.0%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3350525\" data-linked=\"After Hours Gainers / Losers (04/30/2018)\" data-tweet=\"$KPTI $KPTI $INGN - After Hours Gainers / Losers (04/30/2018) https://seekingalpha.com/news/3350525-after-hours-gainers-losers-04-30-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3350525-after-hours-gainers-losers-04-30-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350524\" data-ts=\"1525124105\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/THC\" target=\"_blank\">THC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350524-tenet-healthcare-q1-top-line-down-2-non-gaap-ebitda-up-26-cash-flow-down-39-earnings-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tenet Healthcare Q1 top line down 2%; non-GAAP EBITDA up 26%; cash flow down 39%; earnings guidance raised; shares up 5% after hours</a></h4><ul><li>Tenet Healthcare (NYSE:<a href='https://seekingalpha.com/symbol/THC' title='Tenet Healthcare Corporation'>THC</a>) <a href=\"https://seekingalpha.com/pr/17146223-tenet-reports-results-first-quarter-ended-march-31-2018\" target=\"_blank\">Q1 results </a>($M): Revenues: 4,699 (-2.4%).</li><li>Net income: 99 (+286.8%); non-GAAP net income: 59 (+318.5%); non-GAAP EBITDA: 665 (+26.2%); EPS: 0.96 (+281.1%); non-GAAP EPS: 0.57 (+311.1%); cash flow ops: 113 (-39.2%).</li><li><strong>2018 Guidance</strong>: Revenue: $17.9B - 18.3B (unch); non-GAAP EBITDA: $2.55B - 2.65B from $2.5B - 2.6B; non-GAAP free cash flow: $725M - 925M; EPS: $1.02 - 1.75 from $0.92 - 1.02; non-GAAP EPS: $1.36 - 1.70 from $0.73 - 1.07.</li><li><strong>Q2 Guidance</strong>: Revenue: $4.475B - 4.675B; net income: ($5M) - 10M; EPS: ($0.05) - 0.10; non-GAAP EPS: $0.15 - 0.29.</li><li>Shares are up&nbsp;<font color='green'>5%</font>&nbsp;after hours on modest volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3350524\" data-linked=\"Tenet Healthcare Q1 top line down 2%; non-GAAP EBITDA up 26%; cash flow down 39%; earnings guidance raised; shares up 5% after hours\" data-tweet=\"$THC - Tenet Healthcare Q1 top line down 2%; non-GAAP EBITDA up 26%; cash flow down 39%; earnings guidance raised; shares up 5% after hours https://seekingalpha.com/news/3350524-tenet-healthcare-q1-top-line-down-2-non-gaap-ebitda-up-26-cash-flow-down-39-earnings-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3350524-tenet-healthcare-q1-top-line-down-2-non-gaap-ebitda-up-26-cash-flow-down-39-earnings-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350515\" data-ts=\"1525123152\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APTI\" target=\"_blank\">APTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350515-apptioplus-4_7-after-q1-beats-upside-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apptio +4.7% after Q1 beats, upside guidance</a></h4><ul><li>        Apptio (NASDAQ:<a href='https://seekingalpha.com/symbol/APTI' title='Apptio'>APTI</a>) shares<font color='green'>&nbsp;</font><font color='green'>pop 4.7%</font>&nbsp;aftermarket on Q1 results that beat EPS And revenue estimates with a 23% Y/Y growth in revenue. Upside Q2 guidance has revenue of $55M to $56M (consensus: $53.44M).</li><li>               Upside FY18 guidance has revenue from $225M to $230M (consensus: $223M) and the company expects to report positive operating income.&nbsp;</li><li>                  The earnings call started at 5 PM Eastern with the webcast/replay available <a href=\"http://investors.apptio.com/\" target=\"_blank\">here</a>.    </li><li>               <a href=\"https://seekingalpha.com/pr/17146214-apptio-announces-results-first-quarter-2018\" target=\"_blank\">Press release</a>. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3350440-apptio-beats-0_06-beats-revenue\" target=\"_blank\">Apptio beats by $0.06, beats on revenue</a> (April 30)</li></ul><div class=\"tiny-share-widget\" data-id=\"3350515\" data-linked=\"Apptio +4.7% after Q1 beats, upside guidance\" data-tweet=\"$APTI - Apptio +4.7% after Q1 beats, upside guidance https://seekingalpha.com/news/3350515-apptioplus-4_7-after-q1-beats-upside-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3350515-apptioplus-4_7-after-q1-beats-upside-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350505\" data-ts=\"1525122464\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AKAM\" target=\"_blank\">AKAM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350505-akamai-techplus-4_1-on-upside-q2-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Akamai Tech +4.1% on upside Q2 guidance</a></h4><ul><li>        Akamai Tech (NASDAQ:<a href='https://seekingalpha.com/symbol/AKAM' title='Akamai Technologies, Inc.'>AKAM</a>) provides Q2 and FY18 guidance on the earnings call.</li><li>               Upside Q2 guidance has revenue from $658M to $670M (consensus: $656.63) and EPS from $0.79 to $0.83 (consensus: $0.70).&nbsp;&nbsp;</li><li>               FY18 guidance was raised to in-line revenue of $2.69B to $2.72B (consensus: $2.7B; was: $2.67B to $2.71B) and upside EPS from $3.15 to $3.25 (consensus: $3.01; was: $2.90 to $3.01).&nbsp;</li><li>               Akamai shares are&nbsp;<font color='green'>up 4.1%</font>&nbsp;aftermarket to $74.58.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3350439-akamai-tech-plus-2_3-percent-q1-beats-11-percent-revenue-growth\" target=\"_blank\">Akamai Tech +2.3% on Q1 beats, 11% revenue growth</a> (April 30)</li></ul><div class=\"tiny-share-widget\" data-id=\"3350505\" data-linked=\"Akamai Tech +4.1% on upside Q2 guidance\" data-tweet=\"$AKAM - Akamai Tech +4.1% on upside Q2 guidance https://seekingalpha.com/news/3350505-akamai-techplus-4_1-on-upside-q2-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3350505-akamai-techplus-4_1-on-upside-q2-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350496\" data-ts=\"1525122018\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KPTI\" target=\"_blank\">KPTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350496-karyopharms-selinexor-shows-treatment-effect-in-mid-stage-myeloma-study-shares-up-22-after\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Karyopharm&#39;s selinexor shows treatment effect in mid-stage myeloma study; shares up 22% after hours</a></h4><ul><li>Karyopharm Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/KPTI' title='Karyopharm Therapeutics Inc.'>KPTI</a>) is up&nbsp;<font color='green'>22%</font>&nbsp;after hours on robust volume in response to its <a href=\"https://seekingalpha.com/pr/17146150-karyopharm-announces-positive-top-line-data-phase-2b-storm-study-evaluating-selinexor\" target=\"_blank\">announcement </a>of positive results from its Phase 2b STORM study evaluating selinexor in heavily pretreated multiple myeloma patients, a Fast Track indication.</li><li>The overall response rate was 25.4%, including two complete responses and 29 partial responses. Mean duration of response was 4.4 months. Both are very positive results for this population of treatment-resistant patients.</li><li>The company plans to submit a U.S. marketing application in H2 followed by an application in Europe in Q1 2019.</li><li>Management will host a conference call tomorrow, May 1, at 8:00 am ET to discuss the results.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3350313-karyopharm-17-percent-ahead-mid-stage-selinexor-data\" target=\"_blank\">Karyopharm down 17% ahead of mid-stage selinexor data</a> (April 30)</li></ul><div class=\"tiny-share-widget\" data-id=\"3350496\" data-linked=\"Karyopharm&#39;s selinexor shows treatment effect in mid-stage myeloma study; shares up 22% after hours\" data-tweet=\"$KPTI - Karyopharm&#39;s selinexor shows treatment effect in mid-stage myeloma study; shares up 22% after hours https://seekingalpha.com/news/3350496-karyopharms-selinexor-shows-treatment-effect-in-mid-stage-myeloma-study-shares-up-22-after?source=tweet\" data-url=\"https://seekingalpha.com/news/3350496-karyopharms-selinexor-shows-treatment-effect-in-mid-stage-myeloma-study-shares-up-22-after\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350480\" data-ts=\"1525121075\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CGNX\" target=\"_blank\">CGNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350480-cognexminus-15_9-on-q1-misses-downside-guidance-revenue-warning\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cognex -15.9% on Q1 misses, downside guidance, revenue warning</a></h4><ul><li>        Cognex (NASDAQ:<a href='https://seekingalpha.com/symbol/CGNX' title='Cognex Corporation'>CGNX</a>) shares&nbsp;<font color='red'>plunge 15.9%</font>&nbsp;aftermarket on Q1 results that missed on EPS and revenue estimates. Downside Q2 guidance has revenue from $200M to $210M (consensus: $216.07).</li><li>               Key metrics: Gross margin, 76% (-1 percentage point Y/Y); cash and equivalents, $803M; Debt, $0; cash from operations, $55M; share repurchase, $69M; dividends, $8M; capital expenditures, $13M.&nbsp;</li><li>               Key quote from founder/CEO Robert J. Shillman: &ldquo;Following a record year in 2017, we face tough comparisons this year, particularly in the second half, due to anticipated lower demand from consumer electronics&mdash;our largest industry vertical. Because of that, we believe that Cognex revenue over the next nine months will be relatively flat in total with the comparable period in 2017.&rdquo;</li><li>                  Earnings call is scheduled for 5 PM Eastern with a webcast available <a href=\"http://cgnx.client.shareholder.com/\" target=\"_blank\">here</a>.    </li><li>               <a href=\"https://seekingalpha.com/pr/17146183-cognex-reports-results-first-quarter-2018\" target=\"_blank\">Press release</a>&nbsp; &nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3350420-cognex-misses-0_02-misses-revenue\" target=\"_blank\">Cognex misses by $0.02, misses on revenue</a> (April 30)</li></ul><div class=\"tiny-share-widget\" data-id=\"3350480\" data-linked=\"Cognex -15.9% on Q1 misses, downside guidance, revenue warning\" data-tweet=\"$CGNX - Cognex -15.9% on Q1 misses, downside guidance, revenue warning https://seekingalpha.com/news/3350480-cognexminus-15_9-on-q1-misses-downside-guidance-revenue-warning?source=tweet\" data-url=\"https://seekingalpha.com/news/3350480-cognexminus-15_9-on-q1-misses-downside-guidance-revenue-warning\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350467\" data-ts=\"1525120413\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ELVT\" target=\"_blank\">ELVT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350467-elevate-credit-beats-0_09-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Elevate Credit beats by $0.09, beats on revenue</a></h4><ul><li>Elevate Credit (NYSE:<a href='https://seekingalpha.com/symbol/ELVT' title='Elevate Credit'>ELVT</a>): Q1 EPS of $0.22 <font color='green'>beats by $0.09</font>.</li><li>Revenue of $193.5M (+23.7% Y/Y) <font color='green'>beats by $4.83M</font>.</li><li>Shares <font color='green'>+7.85%</font>.</li><li><a href='https://seekingalpha.com/pr/17146256-elevate-credit-first-quarter-2018-earnings-release-available-investor-relations-website'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3350467\" data-linked=\"Elevate Credit beats by $0.09, beats on revenue\" data-tweet=\"$ELVT - Elevate Credit beats by $0.09, beats on revenue https://seekingalpha.com/news/3350467-elevate-credit-beats-0_09-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3350467-elevate-credit-beats-0_09-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:33 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350464\" data-ts=\"1525120251\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IDTI\" target=\"_blank\">IDTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350464-integrated-device-tech-reports-q4-beats-28-revenue-growth\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Integrated Device Tech reports Q4 beats, 28% revenue growth</a></h4><ul><li>        Integrated Device Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/IDTI' title='Integrated Device Technology, Inc.'>IDTI</a>) shares are up 0.6% aftermarket on Q4 results that beat EPS and revenue estimates with a 28% Y/Y revenue growth. &nbsp;</li><li>        Key metrics: Gross profit, 62.6% (+2.2 percentage points Y/Y); R&amp;D expenses, $42.2M (+$1.2M); SG&amp;A expense, $30.9M (+$3.7M).</li><li>               Quiet Period: IDT&rsquo;s next Quiet Period will start June 18 and extend until when the Q1 FY19 earnings release is published.&nbsp;</li><li>               The earnings call is scheduled for 4:30 PM Eastern with a webcast available <a href=\"http://ir.idt.com/\" target=\"_blank\">here</a>.&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/17146175-idt-reports-fiscal-2018-q4-full-year-financial-results\" target=\"_blank\">Press release</a>&nbsp; &nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3350411-integrated-device-tech-beats-0_02-beats-revenue\" target=\"_blank\">Integrated Device Tech beats by $0.02, beats on revenue</a> (April 30)</li></ul><div class=\"tiny-share-widget\" data-id=\"3350464\" data-linked=\"Integrated Device Tech reports Q4 beats, 28% revenue growth\" data-tweet=\"$IDTI - Integrated Device Tech reports Q4 beats, 28% revenue growth https://seekingalpha.com/news/3350464-integrated-device-tech-reports-q4-beats-28-revenue-growth?source=tweet\" data-url=\"https://seekingalpha.com/news/3350464-integrated-device-tech-reports-q4-beats-28-revenue-growth\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:30 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350439\" data-ts=\"1525119408\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AKAM\" target=\"_blank\">AKAM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350439-akamai-techplus-2_3-on-q1-beats-11-revenue-growth\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Akamai Tech +2.3% on Q1 beats, 11% revenue growth</a></h4><ul><li>        Akamai Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/AKAM' title='Akamai Technologies, Inc.'>AKAM</a>) shares are&nbsp;<font color='green'>up 2.3%</font>&nbsp;aftermarket on Q1 results that beat EPS and revenue estimates with an 11% revenue growth Y/Y. Guidance will come on the earnings call.</li><li>               Revenue breakdown: Web Division, $353M (+16 Y/Y); Media and Carrier Division, $316M (+6%); Cloud Security Solutions, $149M (+36%); Internet Platform Customers, $44M (-14%).&nbsp;</li><li>               Key metrics: Income from operations, $167M (+7%); operating margin, 25% (-1 percentage point due to two acquisition completions); adjusted EBITDA, $256M (+11%); cash from operations, $192M; cash and equivalents, $1.3B; share repurchases, $20M.&nbsp;</li><li>                  The earnings call is scheduled for 4:30 PM Eastern with a webcast available <a href=\"http://www.ir.akamai.com/phoenix.zhtml?c=75943&amp;p=irol-irhome\" target=\"_blank\">here</a>.    </li><li>               <a href=\"https://seekingalpha.com/pr/17146128-akamai-reports-first-quarter-2018-financial-results\" target=\"_blank\">Press release.</a>&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3350403-akamai-beats-0_09-beats-revenue\" target=\"_blank\">Akamai beats by $0.09, beats on revenue</a> (April 30)</li></ul><div class=\"tiny-share-widget\" data-id=\"3350439\" data-linked=\"Akamai Tech +2.3% on Q1 beats, 11% revenue growth\" data-tweet=\"$AKAM - Akamai Tech +2.3% on Q1 beats, 11% revenue growth https://seekingalpha.com/news/3350439-akamai-techplus-2_3-on-q1-beats-11-revenue-growth?source=tweet\" data-url=\"https://seekingalpha.com/news/3350439-akamai-techplus-2_3-on-q1-beats-11-revenue-growth\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:16 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350433\" data-ts=\"1525119260\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INGN\" target=\"_blank\">INGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350433-inogen-beats-0_19-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Inogen beats by $0.19, beats on revenue</a></h4><ul><li>Inogen (NASDAQ:<a href='https://seekingalpha.com/symbol/INGN' title='Inogen, Inc'>INGN</a>): Q1 EPS of $0.48 <font color='green'>beats by $0.19</font>.</li><li>Revenue of $79.05M (+50.6% Y/Y) <font color='green'>beats by $15.19M</font>.</li><li>Shares <font color='green'>+13.81%</font>.</li><li><a href='https://seekingalpha.com/pr/17146135-inogen-announces-record-first-quarter-2018-financial-results-increases-2018-guidance'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3350433\" data-linked=\"Inogen beats by $0.19, beats on revenue\" data-tweet=\"$INGN - Inogen beats by $0.19, beats on revenue https://seekingalpha.com/news/3350433-inogen-beats-0_19-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3350433-inogen-beats-0_19-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:14 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350425\" data-ts=\"1525119098\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TXRH\" target=\"_blank\">TXRH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350425-texas-roadhouse-battles-through-labor-inflation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Texas Roadhouse battles through labor inflation</a></h4><ul>     <li>Texas Roadhouse (NASDAQ:<a href='https://seekingalpha.com/symbol/TXRH' title='Texas Roadhouse, Inc.'>TXRH</a>) is slightly higher after reporting Q1 earnings and setting guidance largely in-line with expectations.</li>     <li>Company-owned comparable sales were up 4.9% to top the consensus estimate for a 4.1% gain. Domestic franchised restaurants saw a 3.9% increase in comparable sales.</li>     <li>Restaurant margin fell 75 bps to 19.2% of sales during the quarter as \"ongoing\" labor inflation was flet.</li>     <li>Looking ahead, Texas Roadhouse expects positive comparable restaurant sales growth and 30 restaurant openings, in 2018. Mid-single digit growth in labor dollars per store week, excluding the impact of higher guest counts, is also anticipated. Guidance also includes an expectation for an income tax rate of 15.0% to 16.0% and total capital expenditures of approximately $165M&nbsp;to $175M.</li>     <li>TXRH&nbsp;<font color='green'>+0.62% AH&nbsp;</font>to $64.50.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3350412-texas-roadhouse-eps-line-beats-revenue\" target=\"_blank\">Texas Roadhouse EPS in-line, beats on revenue</a> (April 30)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3350425\" data-linked=\"Texas Roadhouse battles through labor inflation\" data-tweet=\"$TXRH - Texas Roadhouse battles through labor inflation https://seekingalpha.com/news/3350425-texas-roadhouse-battles-through-labor-inflation?source=tweet\" data-url=\"https://seekingalpha.com/news/3350425-texas-roadhouse-battles-through-labor-inflation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:11 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350421\" data-ts=\"1525119019\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALSN\" target=\"_blank\">ALSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350421-allison-transmission-beats-0_29-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Allison Transmission beats by $0.29, beats on revenue</a></h4><ul><li>Allison Transmission (NYSE:<a href='https://seekingalpha.com/symbol/ALSN' title='Allison Transmission'>ALSN</a>): Q1 EPS of $1.08 <font color='green'>beats by $0.29</font>.</li><li>Revenue of $663M (+32.9% Y/Y) <font color='green'>beats by $88.29M</font>.</li><li>Shares <font color='green'>+1.69%</font>.</li><li><a href='https://seekingalpha.com/pr/17146174-allison-transmission-announces-first-quarter-2018-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3350421\" data-linked=\"Allison Transmission beats by $0.29, beats on revenue\" data-tweet=\"$ALSN - Allison Transmission beats by $0.29, beats on revenue https://seekingalpha.com/news/3350421-allison-transmission-beats-0_29-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3350421-allison-transmission-beats-0_29-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350412\" data-ts=\"1525118805\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TXRH\" target=\"_blank\">TXRH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350412-texas-roadhouse-eps-in-line-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Texas Roadhouse EPS in-line, beats on revenue</a></h4><ul><li>Texas Roadhouse (NASDAQ:<a href='https://seekingalpha.com/symbol/TXRH' title='Texas Roadhouse, Inc.'>TXRH</a>): Q1 EPS of $0.76 in-line.</li><li>Revenue of $627.71M (+10.6% Y/Y) <font color='green'>beats by $1.97M</font>.</li><li>Shares <font color='green'>+1.53%</font>.</li><li><a href='https://seekingalpha.com/pr/17146131-texas-roadhouse-inc-announces-first-quarter-2018-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3350412\" data-linked=\"Texas Roadhouse EPS in-line, beats on revenue\" data-tweet=\"$TXRH - Texas Roadhouse EPS in-line, beats on revenue https://seekingalpha.com/news/3350412-texas-roadhouse-eps-in-line-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3350412-texas-roadhouse-eps-in-line-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:06 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350410\" data-ts=\"1525118737\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350410-analysts-and-investors-make-predictions-ahead-of-apple-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts and investors make predictions ahead of Apple earnings</a></h4><ul><li>           Investors and analysts are making some final predictions ahead of tomorrow&rsquo;s Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) earnings report, which could include light iPhone sales and a record-breaking capital allocation announcement. </li><li> Bernstein&rsquo;s Toni Sacconaghi <a href=\"https://www.reuters.com/article/us-apple-results-preview/investors-look-to-apples-cash-services-as-iphone-sales-seen-stalling-idUSKBN1I11XP?feedType=RSS&amp;feedName=businessNews&amp;utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+reuters%2FbusinessNews+%28Business+News%29\" target=\"_blank\">expects</a> as few as 51M iPhones sold (consensus: 54M; last year: 50.7M). </li><li> Consensus estimates fro iPhone revenue has dropped from $39.7B in mid-April to $39.2B. </li><li> Gullane Capital Partners managing partner Trip Miller is more concerned with revenue in the Services segment, which missed analyst expectations in the last quarter with $8.6B. Consensus puts this quarter at $8.4B. </li><li> Loup Ventures&rsquo; Gene Munster <a href=\"https://www.bloomberg.com/news/articles/2018-04-30/apple-s-service-revenue-closes-in-on-30-billion-a-year-chart\" target=\"_blank\">thinks services</a> will grow 18% to 20% in the quarter. </li><li> Apple execs want the business to hit $50B annually by 2021. </li><li> Apple shares closed today&nbsp;<font color='green'>up 1.8%</font>&nbsp;to $165.26.&nbsp; </li><li>Previously: <a href=\"https://seekingalpha.com/news/3350385-apple-gains-expectations-record-capital-allocation-program\" target=\"_blank\">Apple gains on expectations of record capital allocation program</a> (April 30)</li></ul><div class=\"tiny-share-widget\" data-id=\"3350410\" data-linked=\"Analysts and investors make predictions ahead of Apple earnings\" data-tweet=\"$AAPL - Analysts and investors make predictions ahead of Apple earnings https://seekingalpha.com/news/3350410-analysts-and-investors-make-predictions-ahead-of-apple-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3350410-analysts-and-investors-make-predictions-ahead-of-apple-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>54&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350407\" data-ts=\"1525118692\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTRI\" target=\"_blank\">NTRI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350407-nutrisystem-beats-0_03-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nutrisystem beats by $0.03, beats on revenue</a></h4><ul><li>Nutrisystem (NASDAQ:<a href='https://seekingalpha.com/symbol/NTRI' title='Nutrisystem Inc'>NTRI</a>): Q1 EPS of $0.09 <font color='green'>beats by $0.03</font>.</li><li>Revenue of $210.93M (-0.8% Y/Y) <font color='green'>beats by $3.63M</font>.</li><li>Shares <font color='green'>+10.34%</font>.</li><li><a href='https://seekingalpha.com/pr/17146116-nutrisystem-announces-first-quarter-2018-financial-results-exceeding-revenue-eps-expectations'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3350407\" data-linked=\"Nutrisystem beats by $0.03, beats on revenue\" data-tweet=\"$NTRI - Nutrisystem beats by $0.03, beats on revenue https://seekingalpha.com/news/3350407-nutrisystem-beats-0_03-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3350407-nutrisystem-beats-0_03-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350403\" data-ts=\"1525118579\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AKAM\" target=\"_blank\">AKAM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350403-akamai-beats-0_09-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Akamai beats by $0.09, beats on revenue</a></h4><ul><li>Akamai (NASDAQ:<a href='https://seekingalpha.com/symbol/AKAM' title='Akamai Technologies, Inc.'>AKAM</a>): Q1 EPS of $0.79 <font color='green'>beats by $0.09</font>.</li><li>Revenue of $668.72M (+11.4% Y/Y) <font color='green'>beats by $14.44M</font>.</li><li>Shares <font color='green'>+1.8%</font>.</li><li><a href='https://seekingalpha.com/pr/17146128-akamai-reports-first-quarter-2018-financial-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3350403\" data-linked=\"Akamai beats by $0.09, beats on revenue\" data-tweet=\"$AKAM - Akamai beats by $0.09, beats on revenue https://seekingalpha.com/news/3350403-akamai-beats-0_09-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3350403-akamai-beats-0_09-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350398\" data-ts=\"1525118396\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DO\" target=\"_blank\">DO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350398-diamond-offshoreminus-3-ceo-says-floater-category-still-faces-headwinds\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Diamond Offshore -3% as CEO says floater category still faces headwinds</a></h4><ul>     <li>Diamond Offshore (<a href='https://seekingalpha.com/symbol/DO' title='Diamond Offshore Drilling Inc.'>DO</a> <font color='red'>-3.3%</font>) drifts toward its lows of the day after reporting a smaller than expected <a href=\"https://seekingalpha.com/news/3350115-diamond-offshore-drilling-beats-0_03-beats-revenue\" target=\"_blank\">Q1 loss</a> alongside a 21% Y/Y decline in revenues.</li><li>DO says Q1 rig utilization came in at 52% from 47 % in the year-ago quarter but average day rates fell 4% to $351K; total operating efficiency was 97% vs. 94.1% in the prior-year quarter.</li>     <li>In its <a href=\"https://seekingalpha.com/article/4167590-diamond-offshore-drillings-ceo-marc-edwards-q1-2018-results-earnings-call-transcript\" target=\"_blank\">earnings conference call</a>, DO CEO Marc Edwards said the floater category <a href=\"https://www.reuters.com/article/brief-diamond-offshore-ceo-says-floater/brief-diamond-offshore-ceo-says-floater-category-still-facing-many-headwinds-idUSFWN1S70RB\" target=\"_blank\">still faces many headwinds</a> and he remains cautious on the deepwater drillship segment but that the group may be close to approaching bottom in both utilization and pricing.</li></ul><div class=\"tiny-share-widget\" data-id=\"3350398\" data-linked=\"Diamond Offshore -3% as CEO says floater category still faces headwinds\" data-tweet=\"$DO - Diamond Offshore -3% as CEO says floater category still faces headwinds https://seekingalpha.com/news/3350398-diamond-offshoreminus-3-ceo-says-floater-category-still-faces-headwinds?source=tweet\" data-url=\"https://seekingalpha.com/news/3350398-diamond-offshoreminus-3-ceo-says-floater-category-still-faces-headwinds\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350384\" data-ts=\"1525114827\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPCB\" target=\"_blank\">SPCB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350384-technology-top-5-gainers-losers-of-3-00-pm-04-30-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 3:00 PM (04/30/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/SPCB' title='SuperCom, Ltd.'>SPCB</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/HEAR' title='Turtle Beach Corporation'>HEAR</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/VERI' title='Veritone'>VERI</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/BITA' title='Bitauto Holdings Limited'>BITA</a> <font color='green'>+5%</font>. <a href='https://seekingalpha.com/symbol/SHOP' title='Shopify'>SHOP</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/UAVS' title='AgEagle'>UAVS</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/S' title='Sprint Corporation'>S</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/MTSL' title='MER Telemanagement Solutions Ltd.'>MTSL</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/RENN' title='Renren Inc.'>RENN</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/STRM' title='Streamline Health Solutions, Inc.'>STRM</a> <font color='red'>-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3350384\" data-linked=\"Technology - Top 5 Gainers / Losers as of 3:00 PM (04/30/2018)\" data-tweet=\"$SPCB $SPCB $HEAR - Technology - Top 5 Gainers / Losers as of 3:00 PM (04/30/2018) https://seekingalpha.com/news/3350384-technology-top-5-gainers-losers-of-3-00-pm-04-30-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3350384-technology-top-5-gainers-losers-of-3-00-pm-04-30-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350385\" data-ts=\"1525114824\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350385-apple-gains-on-expectations-of-record-capital-allocation-program\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apple gains on expectations of record capital allocation program</a></h4><ul><li>        Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) shares are gaining ahead of earnings tomorrow and investor/analyst believe that the report could include a <a href=\"https://www.cnbc.com/2018/04/30/apple-shares-jump-on-optimism-for-a-big-boost-to-buyback-dividend-program.html\" target=\"_blank\">record capital allocation program</a>.</li><li>               Morgan Stanley thinks Apple could increase the capital return program by $150B.&nbsp;</li><li>               Analyst Katy Huberty expects $210B in share repurchases, $52B in dividends over three years, and about $30B left on the table for acquisitions.&nbsp;</li><li>               More estimates: Citi thinks the program will expand by $100B. GBH Insights analyst Daniel Ives thinks Apple will repatriate $200B.&nbsp;</li><li>               In January, Apple said it expects to pay $38B taxes on what it plans to repatriate, implying it will bring back nearly all of its $250B in overseas profits.&nbsp;</li><li>               Apple shares are&nbsp;<font color='green'>up 1.6%</font>&nbsp;to $164.92.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3350328-barclays-thinks-new-iphones-include-headphone-adapter\" target=\"_blank\">Barclays thinks new iPhones won't include headphone adapter</a> (April 30)</li></ul><div class=\"tiny-share-widget\" data-id=\"3350385\" data-linked=\"Apple gains on expectations of record capital allocation program\" data-tweet=\"$AAPL - Apple gains on expectations of record capital allocation program https://seekingalpha.com/news/3350385-apple-gains-on-expectations-of-record-capital-allocation-program?source=tweet\" data-url=\"https://seekingalpha.com/news/3350385-apple-gains-on-expectations-of-record-capital-allocation-program\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>72&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350337\" data-ts=\"1525114215\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MCY\" target=\"_blank\">MCY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350337-mercury-general-slides-6_2-post-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mercury General slides 6.2% post Q1 results.</a></h4><ul><li>Mercury General (<a href='https://seekingalpha.com/symbol/MCY' title='Mercury General Corporation'>MCY</a> <font color='red'>-7.3%</font>) <a href=\"https://seekingalpha.com/filing/3994514\" target=\"_blank\">reports Q1</a> revenue of $783.18M (-7.6% Y/Y);&nbsp;Net premiums earned was $808.1M (+2.3% Y/Y);&nbsp;Net premium written of $861.3M (+6.1% Y/Y) &amp;&nbsp;Net investment income of $31.5M (+1% Y/Y).</li><li>Loss ratio was up&nbsp;<font color='green'>140 bps</font>&nbsp;to 78.2%;&nbsp;Expense ratio&nbsp;down&nbsp;<font color='red'>80 bps</font>&nbsp;to 25.5% &amp; Combined ratio up&nbsp;<font color='green'>70 bps</font>&nbsp;to 103.8%.</li><li>Statutory surplus of $1.56B (-1.9% Y/Y); Net premiums written to surplus ratio was 2.1%; Debt to total capital ratio up&nbsp;<font color='green'>60 bps</font>&nbsp;to 18.2%.</li><li>Policies-In-Force: Personal auto 1,134 (+1.2% Y/Y); Homeowners 563 (+1.8% Y/Y)&nbsp;&amp; Commercial auto 39 (-2.5% Y/Y)</li><li>Average invested assets at cost was up 3.7% Y/Y to $3.6B &amp; average annual yield on investments remained the same to 3.1%.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3350219-mercury-general-eps-0_07\" target=\"_blank\">Mercury General EPS of $0.07</a> (April 30)</li></ul><div class=\"tiny-share-widget\" data-id=\"3350337\" data-linked=\"Mercury General slides 6.2% post Q1 results.\" data-tweet=\"$MCY - Mercury General slides 6.2% post Q1 results. https://seekingalpha.com/news/3350337-mercury-general-slides-6_2-post-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3350337-mercury-general-slides-6_2-post-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:50 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350383\" data-ts=\"1525114167\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOOG\" target=\"_blank\">GOOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350383-google-launches-nvidia-tesla-v100-gpus-on-cloud\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Google launches Nvidia Tesla V100 GPUS on cloud</a></h4><ul><li>        Google (<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet, Inc. Cl C'>GOOG</a>, <a href='https://seekingalpha.com/symbol/GOOGL' title='Alphabet, Inc. Cl A'>GOOGL</a>) <a href=\"https://techcrunch.com/2018/04/30/google-brings-nvidias-tesla-v100-gpus-to-its-cloud/\" target=\"_blank\">announces</a> that Nvidia&rsquo;s (NASDAQ:<a href='https://seekingalpha.com/symbol/NVDA' title='NVIDIA Corporation'>NVDA</a>) Tesla V100 GPUs are now available for workloads on Compute Engine and Kubernetes Engine on its cloud.</li><li>               The Nvidia P100 GPUS are also now out of beta and publicly available.&nbsp;</li><li>               Amazon Web Services and IBM already offer V100s, the most powerful GPUs Nvidia makes for high-performance computing, and Microsoft&rsquo;s Azure has them in private preview.&nbsp;</li><li>               Nvidia shares are&nbsp;<font color='red'>down 0.8%</font>&nbsp;to $224.45.&nbsp;</li><li>               GOOGL shares are&nbsp;<font color='red'>down 1%</font>.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3350261-fitbit-plus-6_8-percent-health-collaboration-google\" target=\"_blank\">Fitbit +6.8% on health collaboration with Google</a> (April 30)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3350323-supreme-court-considers-class-action-compensation-rules-google-case\" target=\"_blank\">Supreme Court considers class-action compensation rules with Google case</a> (April 30)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3350329-nbcu-google-partner-new-list-vr-projects\" target=\"_blank\">NBCU, Google partner on new list of VR projects</a> (April 30)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3350338-supreme-court-declines-hear-googles-patent-case-appeal\" target=\"_blank\">Supreme Court declines to hear Google's patent case appeal</a> (April 30)</li></ul><div class=\"tiny-share-widget\" data-id=\"3350383\" data-linked=\"Google launches Nvidia Tesla V100 GPUS on cloud\" data-tweet=\"$GOOG $GOOG $GOOGL - Google launches Nvidia Tesla V100 GPUS on cloud https://seekingalpha.com/news/3350383-google-launches-nvidia-tesla-v100-gpus-on-cloud?source=tweet\" data-url=\"https://seekingalpha.com/news/3350383-google-launches-nvidia-tesla-v100-gpus-on-cloud\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>57&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350381\" data-ts=\"1525113645\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOLD\" target=\"_blank\">GOLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350381-barrick-novagold-mining-project-in-alaska-gets-key-environmental-approval\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Barrick, NovaGold mining project in Alaska gets key environmental approval</a></h4><ul>     <li>Barrick Gold (ABX <font color='red'>-1.7%</font>) and NovaGold Resources (<a href='https://seekingalpha.com/symbol/NG' title='NovaGold Resources, Inc'>NG</a> <font color='green'>+0.6%</font>) say their proposed Dolin gold mine in Alaska has <a href=\"http://www.mining.com/barrick-novagold-project-in-alaska-gets-key-environmental-approval/\" target=\"_blank\">received final environmental clearance</a> from the U.S. Army Corps of Engineers.</li><li>The proposed mine, which contains 39M oz. of gold in the measured and indicated (M&amp;I) resource categories, is expected to require a $6.7B investment from the two companies, which are developing the assets in a 50-50 partnership.</li>     <li>The Donlin project to production is expected to take about four years for production to begin but has far to go in the permitting process before  construction and operations can begin.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3350381\" data-linked=\"Barrick, NovaGold mining project in Alaska gets key environmental approval\" data-tweet=\"$GOLD $GOLD $NG - Barrick, NovaGold mining project in Alaska gets key environmental approval https://seekingalpha.com/news/3350381-barrick-novagold-mining-project-in-alaska-gets-key-environmental-approval?source=tweet\" data-url=\"https://seekingalpha.com/news/3350381-barrick-novagold-mining-project-in-alaska-gets-key-environmental-approval\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350380\" data-ts=\"1525113432\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DIS\" target=\"_blank\">DIS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350380-twitter-up-5-after-disney-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Twitter up more than 5% after Disney deal</a></h4><ul><li>The two <a href=\"https://espnmediazone.com/us/press-releases/2018/04/the-walt-disney-company-and-twitter-announce-new-live-content-and-advertising-agreement/\" target=\"_blank\">announce an agreement </a>to create live content and advertising opportunities from across the entire Disney (NYSE:<a href='https://seekingalpha.com/symbol/DIS' title='The Walt Disney Company'>DIS</a>) portfolio on the Twitter (NYSE:<a href='https://seekingalpha.com/symbol/TWTR' title='Twitter, Inc.'>TWTR</a>) platform.</li><li>Twitter and ESPN will announce specific live shows in development at presentations later today and this week.</li><li>TWTR has spiked to a session high,&nbsp;<font color='green'>up 5.3%</font>. Disney remains&nbsp;<font color='green'>up 1.5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3350380\" data-linked=\"Twitter up more than 5% after Disney deal\" data-tweet=\"$DIS $DIS $TWTR - Twitter up more than 5% after Disney deal https://seekingalpha.com/news/3350380-twitter-up-5-after-disney-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3350380-twitter-up-5-after-disney-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>39&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350379\" data-ts=\"1525112924\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BHGE\" target=\"_blank\">BHGE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350379-baker-hughes-w-and-t-offshore-enter-gulf-of-mexico-development-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Baker Hughes, W&amp;T Offshore enter Gulf of Mexico development deal</a></h4><ul>     <li>Baker Hughes (<a href='https://seekingalpha.com/symbol/BHGE' title='Baker Hughes, a GE company'>BHGE</a> <font color='green'>+0.6%</font>) and W&amp;T Offshore (<a href='https://seekingalpha.com/symbol/WTI' title='W&T Offshore, Inc.'>WTI</a> <font color='green'>+3.7%</font>) announce a <a href=\"https://seekingalpha.com/pr/17145609-w-and-t-offshore-baker-hughes-ge-company-announce-strategic-agreement-joint-exploration-and\" target=\"_blank\">joint program to explore and develop</a> as many as 14 drilling projects in the Gulf of&nbsp;Mexico.</li><li>BHGE will provide a full suite of integrated oilfield services and         oilfield equipment including drilling, completions and production, and         subsea production systems for the drilling projects, most of which are operated by W&amp;T.</li><li>&ldquo;This partnership with BHGE is the type of collaborative arrangement       that is enabling renewed activity in the Gulf of Mexico,\" says W&amp;T&nbsp;Chairman and CEO Tracy       Krohn.</li></ul><div class=\"tiny-share-widget\" data-id=\"3350379\" data-linked=\"Baker Hughes, W&amp;T Offshore enter Gulf of Mexico development deal\" data-tweet=\"$BHGE $BKR $WTI - Baker Hughes, W&amp;T Offshore enter Gulf of Mexico development deal https://seekingalpha.com/news/3350379-baker-hughes-w-and-t-offshore-enter-gulf-of-mexico-development-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3350379-baker-hughes-w-and-t-offshore-enter-gulf-of-mexico-development-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350376\" data-ts=\"1525112241\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/S\" target=\"_blank\">S</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350376-deal-done-sprint-and-t-mobile-schedule-earnings-reports\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">With deal done, Sprint and T-Mobile schedule earnings reports</a></h4><ul>   <li>With a <a href=\"https://seekingalpha.com/news/3350089-sprint-t-mobile-officially-announce-merger-26b-deal\" target=\"_blank\">merger deal now part of yesterday's news</a>, Sprint (<a href=\"http://seekingalpha.com/symbol/S\" target=\"_blank\">S</a> <font color='red'>-15%</font>) has <a href=\"https://seekingalpha.com/pr/17145912-sprint-corporation-schedules-fiscal-2017-fourth-quarter-results-announcement\" target=\"_blank\">scheduled its Q4 earnings announcement</a> for Wednesday after the closing bell.</li>    <li>Earlier, merger partner T-Mobile (<a href=\"http://seekingalpha.com/symbol/TMUS\" target=\"_blank\">TMUS</a> <font color='red'>-7.5%</font>) set its own earnings for tomorrow (Tuesday, May 1) after the closing bell. T-Mobile has set its <a href=\"http://investor.t-mobile.com\" target=\"_blank\">earnings call</a> for 4:30 p.m. ET tomorrow.</li>    <li>Sprint will <a href=\"http://www.sprint.com/investors\" target=\"_blank\">hold its call</a> at 4:30 p.m. ET on Wednesday.</li>    <li>With <a href=\"https://seekingalpha.com/news/3350255-sprint-minus-10-percent-t-mobile-minus-2-percent-analysts-fade-merger-approval-chances\" target=\"_blank\">analysts expressing skepticism</a> that the deal can get government approval, Sprint is seeing its worst day in months. Today's low of $5.50 is the <a href=\"https://seekingalpha.com/news/3344726-sprint-t-mobile-jump-report-deal-talks-restarted-updated\" target=\"_blank\">lowest point for Sprint since April 10</a>, when it took a leap based on reports that deal talks had restarted.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3350376\" data-linked=\"With deal done, Sprint and T-Mobile schedule earnings reports\" data-tweet=\"$S $S $TMUS - With deal done, Sprint and T-Mobile schedule earnings reports https://seekingalpha.com/news/3350376-deal-done-sprint-and-t-mobile-schedule-earnings-reports?source=tweet\" data-url=\"https://seekingalpha.com/news/3350376-deal-done-sprint-and-t-mobile-schedule-earnings-reports\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350374\" data-ts=\"1525112124\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EDGE\" target=\"_blank\">EDGE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350374-edge-therapeutics-to-explore-strategic-alternative-shares-down-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Edge Therapeutics to explore strategic alternative; shares down 3%</a></h4><ul><li>Aimed at boosting shareholder value, Edge Therapeutics (<a href='https://seekingalpha.com/symbol/EDGE' title='Edge Therapeutics'>EDGE</a> <font color='red'>-3%</font>) <a href=\"https://seekingalpha.com/pr/17144946-edge-therapeutics-announces-review-strategic-alternatives\" target=\"_blank\">announces </a>that it will review strategic alternatives, including an outright sale of the company. Piper Jaffray is advising.</li><li>It also plans to downsize its operations to extend its cash runway.</li></ul><div class=\"tiny-share-widget\" data-id=\"3350374\" data-linked=\"Edge Therapeutics to explore strategic alternative; shares down 3%\" data-tweet=\"$EDGE $PDSB - Edge Therapeutics to explore strategic alternative; shares down 3% https://seekingalpha.com/news/3350374-edge-therapeutics-to-explore-strategic-alternative-shares-down-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3350374-edge-therapeutics-to-explore-strategic-alternative-shares-down-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:15 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350370\" data-ts=\"1525111561\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SQ\" target=\"_blank\">SQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350370-square-targeted-citron-shares-slip-nearly-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Square targeted by Citron; shares slip nearly 3%</a></h4><ul><li>A \"collection of yawn businesses,\" <a href=\"https://twitter.com/CitronResearch/status/991012672740052994\" target=\"_blank\">says Andrew Left</a>, arguing that what started as an innovative payment company is now just another processor, selling for a very rich valuation.</li><li>He's not impressed with the bitcoin \"nonsense\" either, noting trading on Square's platform has been insignificant.</li><li>His short-term target of $30 implies about&nbsp;<font color='red'>35% downside</font>.</li><li><a href='https://seekingalpha.com/symbol/SQ' title='Square, Inc.'>SQ</a>&nbsp;<font color='red'>-2.7%</font>&nbsp;to $46.28.</li></ul><div class=\"tiny-share-widget\" data-id=\"3350370\" data-linked=\"Square targeted by Citron; shares slip nearly 3%\" data-tweet=\"$SQ - Square targeted by Citron; shares slip nearly 3% https://seekingalpha.com/news/3350370-square-targeted-citron-shares-slip-nearly-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3350370-square-targeted-citron-shares-slip-nearly-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>80&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350369\" data-ts=\"1525111537\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CELG\" target=\"_blank\">CELG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350369-selloff-in-celgene-overdone-evercore\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Selloff in Celgene overdone - Evercore</a></h4><ul><li>Evercore ISI's Umer Raffat (OUTPERFORM/$155) says the selling pressure on Celgene (<a href='https://seekingalpha.com/symbol/CELG' title='Celgene Corporation'>CELG</a> <font color='red'>-5%</font>) is an overreaction to the bear thesis of a one-to-three year delay in refiling its marketing application for MS med ozanimod. He expects the company to resubmit its application by late summer/early fall, adding that the potential two-year animal study related to the safety of principal metabolite <a href=\"https://www.biocentury.com/bc-extra/clinical-news/2018-04-26/metabolite-drives-activity-celgenes-ozanimod\" target=\"_blank\">CC112273 </a>could be done on a post-marketing basis.</li><li>Source: Bloomberg</li><li>Previously: <a href=\"https://seekingalpha.com/news/3350279-celgene-4-percent-extended-timeline-ozanimod-resubmission-u-s\" target=\"_blank\">Celgene down 4% on extended timeline for ozanimod resubmission in U.S.</a> (April 30)</li></ul><div class=\"tiny-share-widget\" data-id=\"3350369\" data-linked=\"Selloff in Celgene overdone - Evercore\" data-tweet=\"$CELG - Selloff in Celgene overdone - Evercore https://seekingalpha.com/news/3350369-selloff-in-celgene-overdone-evercore?source=tweet\" data-url=\"https://seekingalpha.com/news/3350369-selloff-in-celgene-overdone-evercore\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>54&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350368\" data-ts=\"1525111275\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANDV\" target=\"_blank\">ANDV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350368-energy-materials-top-5-gainers-losers-of-2-00-pm-04-30-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top 5 Gainers / Losers as of 2:00 PM (04/30/2018)</a></h4><ul>     <li><strong>Gainers:</strong> <a href='https://seekingalpha.com/symbol/ANDV' title='Andeavor'>ANDV</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/CRR' title='CARBO Ceramics Inc.'>CRR</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/MCEP' title='Mid-Con Energy Partners'>MCEP</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/AHGP' title='Alliance Holdings GP, L.P.'>AHGP</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/ARLP' title='Alliance Resource Partners, L.P.'>ARLP</a> <font color='green'>+6%</font>.</li>     <li><strong>Losers:</strong> <a href='https://seekingalpha.com/symbol/ARNC' title='Arconic Inc'>ARNC</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/ANDX' title='Andeavor Logistics LP'>ANDX</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/MPC' title='Marathon Petroleum Corp.'>MPC</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/FSI' title='Flexible Solutions International, Inc'>FSI</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/AKS' title='AK Steel Holding Corp'>AKS</a> <font color='red'>-6%</font>.</li> &nbsp;     &nbsp; </ul><div class=\"tiny-share-widget\" data-id=\"3350368\" data-linked=\"Energy/Materials - Top 5 Gainers / Losers as of 2:00 PM (04/30/2018)\" data-tweet=\"$ANDV $ANDV $CRR - Energy/Materials - Top 5 Gainers / Losers as of 2:00 PM (04/30/2018) https://seekingalpha.com/news/3350368-energy-materials-top-5-gainers-losers-of-2-00-pm-04-30-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3350368-energy-materials-top-5-gainers-losers-of-2-00-pm-04-30-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350367\" data-ts=\"1525111136\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350367-oil-perky-netanyahu-talks-secret-iran-plan-for-nukes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oil perky as Netanyahu talks about secret Iran plan for nukes</a></h4><ul><li>Speaking to his country in a TV address, the Israeli prime minister says his government has information showing Iran as secretly working to build nuclear weapons.</li><li>Israel intends to share the incriminating documents with the U.S. and the IAEA, says Netanyahu.</li><li>A source tells Bloomberg the U.S. has verified the authenticity of the documents.</li><li>Oil has moved to near session highs,<font color='green'> up 1.15%&nbsp;</font>at $68.95 per barrel.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UWT' title='VelocityShares 3X Long Crude ETN'>UWT</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/DWT' title='VelocityShares 3x Inverse Crude Oil ETN'>DWT</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/DBO' title='PowerShares DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/UGA' title='The United States Gasoline ETF, LP'>UGA</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/USL' title='The United States 12 Month Oil ETF, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/DNO' title='The United States Short Oil ETF, LP'>DNO</a>, <a href='https://seekingalpha.com/symbol/OLO' title='DB Crude Oil Long ETN'>OLO</a>, <a href='https://seekingalpha.com/symbol/UHN' title='The United States Diesel-Heating Oil ETF, LP'>UHN</a>, <a href='https://seekingalpha.com/symbol/SZO' title='DB Crude Oil Short ETN'>SZO</a>, <a href='https://seekingalpha.com/symbol/OLEM' title='iPath Pure Beta Crude Oil ETN'>OLEM</a>, <a href='https://seekingalpha.com/symbol/WTIU' title='ProShares Daily 3x Long Crude ETN'>WTIU</a>, <a href='https://seekingalpha.com/symbol/OILK' title='ProShares K-1 Free Crude Oil Strategy ETF'>OILK</a>, <a href='https://seekingalpha.com/symbol/OILX' title='Etracs S&P GSCI Crude Oil Total Return Index ETN'>OILX</a>, <a href='https://seekingalpha.com/symbol/WTID' title='ProShares Daily 3x Inverse Crude ETN'>WTID</a>, <a href='https://seekingalpha.com/symbol/USOI' title='Credit Suisse Crude Oil Shares Covered Call ETN'>USOI</a>, <a href='https://seekingalpha.com/symbol/USOU' title='United States 3x Oil Fund'>USOU</a>, <a href='https://seekingalpha.com/symbol/USOD' title='United States 3x Short Oil Fund ETF'>USOD</a>, <a href='https://seekingalpha.com/symbol/UBRT' title='Credit Suisse AxelaTrader 3x Long Brent Crude Oil ETN'>UBRT</a>, <a href='https://seekingalpha.com/symbol/DBRT' title='Credit Suisse AxelaTrader 3x Inverse Brent Crude Oil ETN'>DBRT</a>, <a href='https://seekingalpha.com/symbol/OILD' title='ProShares UltraPro 3x Short Crude Oil ETF'>OILD</a>, <a href='https://seekingalpha.com/symbol/OILU' title='ProShares UltraPro 3x Crude Oil ETF'>OILU</a>, <a href='https://seekingalpha.com/symbol/USAI' title='American Energy Independence ETF'>USAI</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3350367\" data-linked=\"Oil perky as Netanyahu talks about secret Iran plan for nukes\" data-tweet=\"$USO $OIL $UWT - Oil perky as Netanyahu talks about secret Iran plan for nukes https://seekingalpha.com/news/3350367-oil-perky-netanyahu-talks-secret-iran-plan-for-nukes?source=tweet\" data-url=\"https://seekingalpha.com/news/3350367-oil-perky-netanyahu-talks-secret-iran-plan-for-nukes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>74&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350364\" data-ts=\"1525110237\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SLDB\" target=\"_blank\">SLDB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350364-solid-biosciences-moving-closer-to-removal-of-clinical-hold-on-early-stage-study-of-dmd\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Solid Biosciences moving closer to removal of clinical hold on early-stage study of DMD candidate SGT-001; shares up 6%</a></h4><ul><li>Thinly traded Solid Biosciences (<a href='https://seekingalpha.com/symbol/SLDB' title='Solid Biosciences, Inc.'>SLDB</a> <font color='green'>+5.5%</font>) is up, albeit on turnover of only 85K shares, on its <a href=\"https://seekingalpha.com/pr/17132945-solid-biosciences-provides-update-sgtminus-001-clinical-development-program-duchenne-muscular\" target=\"_blank\">announcement </a>that it has received a letter from FDA concerning the full clinical hold on its Phase 1/2 study of gene therapy SGT-001 in patients with Duchenne muscular dystrophy. The agency suspended the study after the first participant experienced a severe reaction requiring hospitalization.</li><li>The agency has requested more information related to causes of the serious adverse event, the patient's clinical status and laboratory parameters and any additional measures to address patient safety. It plans to respond to the letter in the next few weeks.</li><li>The company also reports that the FDA has informed it that it has satisfactorily addressed its manufacturing-related questions that led to the partial clinical hold on the high dose of SGT-001, thereby avoiding any revision to its current manufacturing process.</li><li>DMD-related tickers: (<a href='https://seekingalpha.com/symbol/SRPT' title='Sarepta Therapeutics, Inc.'>SRPT</a> <font color='red'>-2%</font>)(<a href='https://seekingalpha.com/symbol/CAPR' title='Capricor Therapeutics, Inc.'>CAPR</a> <font color='green'>+1.5%</font>)(<a href='https://seekingalpha.com/symbol/CATB' title='Catabasis Pharmaceuticals'>CATB</a> <font color='red'>-1.2%</font>)(<a href='https://seekingalpha.com/symbol/PFE' title='Pfizer Inc.'>PFE</a> <font color='red'>-0.3%</font>)(<a href='https://seekingalpha.com/symbol/SMMT' title='Summit Therapeutics'>SMMT</a> <font color='red'>-4.5%</font>)(<a href='https://seekingalpha.com/symbol/WVE' title='Wave Life Sciences'>WVE</a> <font color='red'>-0.7%</font>)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3339432-fda-places-solid-biosciences-dmd-study-lead-candidate-sgtminus-001-clinical-hold-due-adverse\" target=\"_blank\">FDA places Solid Biosciences' DMD study of lead candidate SGT-001 on clinical hold due to adverse event in first patient; shares down 57% premarket</a> (March 15)</li></ul><div class=\"tiny-share-widget\" data-id=\"3350364\" data-linked=\"Solid Biosciences moving closer to removal of clinical hold on early-stage study of DMD candidate SGT-001; shares up 6%\" data-tweet=\"$SLDB $SLDB $SRPT - Solid Biosciences moving closer to removal of clinical hold on early-stage study of DMD candidate SGT-001; shares up 6% https://seekingalpha.com/news/3350364-solid-biosciences-moving-closer-to-removal-of-clinical-hold-on-early-stage-study-of-dmd?source=tweet\" data-url=\"https://seekingalpha.com/news/3350364-solid-biosciences-moving-closer-to-removal-of-clinical-hold-on-early-stage-study-of-dmd\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350361\" data-ts=\"1525109138\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UA\" target=\"_blank\">UA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350361-under-armour-earnings-preview\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Under Armour earnings preview</a></h4><ul>     <li>Investors will be watching Under Armour's (<a href='https://seekingalpha.com/symbol/UA' title='Under Armour, Inc. Class C'>UA</a>, <a href='https://seekingalpha.com/symbol/UAA' title='Under Armour, Inc.'>UAA</a>) sales growth progress in North America very closely when the company reports Q1 earnings tomorrow. Bloomberg Intelligence says that it&rsquo;s too early to call a turnaround for the athletic apparel seller without real signs of increased traction in the domestic market.</li>     <li>Analysts expect UA to post total revenue of $1.12B as international sales growth helps offset a continued decline in North America.</li>     <li>Consensus estimates on the bottom line are for Under Armour to report EPS of $0.17 off a gross margin rate of 45.5%.</li>              <li>Last time around, Under Armour guided for low single-digit sales growth for the full year. Management will probably have to at least match that estimate to keep shares moving in the right direction. Since the Q4 report, UA&nbsp;shares are up over 25%.</li>     </ul><div class=\"tiny-share-widget\" data-id=\"3350361\" data-linked=\"Under Armour earnings preview\" data-tweet=\"$UA $UA $UAA - Under Armour earnings preview https://seekingalpha.com/news/3350361-under-armour-earnings-preview?source=tweet\" data-url=\"https://seekingalpha.com/news/3350361-under-armour-earnings-preview\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350358\" data-ts=\"1525108986\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAPR\" target=\"_blank\">CAPR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350358-capricor-launches-mid-stage-study-of-dmd-candidate-capminus-1002-shares-up-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Capricor launches mid-stage study of DMD candidate CAP-1002; shares up 2%</a></h4><ul><li>Capricor Therapeutics (<a href='https://seekingalpha.com/symbol/CAPR' title='Capricor Therapeutics, Inc.'>CAPR</a> <font color='green'>+1.5%</font>) <a href=\"https://seekingalpha.com/pr/17144960-capricor-announces-initiation-hopeminus-2-clinical-trial-capminus-1002-duchenne-muscular\" target=\"_blank\">initiates </a>a Phase 2 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT03406780?titles=hope-2&amp;spons=capricor&amp;phase=1&amp;rank=1\" target=\"_blank\">HOPE-2</a>, assessing CAP-1002 in boys and young men with Duchenne muscular dystrophy &#40;DMD&#41;.</li><li>The 84-subject study will be conducted at 12 - 15 sites in the U.S. UC Davis Medical Center in Sacramento, CA, is first to come online. The primary endpoint is the change in the mid-level dimension of the <a href=\"https://www.sciencedirect.com/science/article/pii/S0960896613010201\" target=\"_blank\">Performance of the Upper Limb</a> test at month 12. According to ClinicalTrials.gov, the estimated primary completion date is December 2019.</li><li><a href=\"http://capricor.com/product-pipeline/cap-1002/\" target=\"_blank\">CAP-1002</a>&nbsp;is an investigational allogeneic, off-the-shelf cardiac cell therapy derived from donor heart tissue and infused directly into the patient's coronary artery via a catheter.</li><li>DMD-related tickers: (<a href='https://seekingalpha.com/symbol/SRPT' title='Sarepta Therapeutics, Inc.'>SRPT</a> <font color='red'>-2.1%</font>)(<a href='https://seekingalpha.com/symbol/CATB' title='Catabasis Pharmaceuticals'>CATB</a> <font color='red'>-0.6%</font>)(<a href='https://seekingalpha.com/symbol/PFE' title='Pfizer Inc.'>PFE</a> <font color='red'>-0.5%</font>)(<a href='https://seekingalpha.com/symbol/SLDB' title='Solid Biosciences, Inc.'>SLDB</a> <font color='green'>+5.8%</font>)(<a href='https://seekingalpha.com/symbol/WVE' title='Wave Life Sciences'>WVE</a> <font color='red'>-0.7%</font>)(<a href='https://seekingalpha.com/symbol/SMMT' title='Summit Therapeutics'>SMMT</a> <font color='red'>-4.1%</font>)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3328017-capricor-nabs-accelerated-review-status-u-s-duchenne-candidate-capminus-1002-shares-9-percent\" target=\"_blank\">Capricor nabs accelerated review status in U.S. for Duchenne candidate CAP-1002; shares up 9% premarket</a> (Feb. 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3350358\" data-linked=\"Capricor launches mid-stage study of DMD candidate CAP-1002; shares up 2%\" data-tweet=\"$CAPR $CAPR $SRPT - Capricor launches mid-stage study of DMD candidate CAP-1002; shares up 2% https://seekingalpha.com/news/3350358-capricor-launches-mid-stage-study-of-dmd-candidate-capminus-1002-shares-up-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3350358-capricor-launches-mid-stage-study-of-dmd-candidate-capminus-1002-shares-up-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:23 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350356\" data-ts=\"1525108980\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/USCR\" target=\"_blank\">USCR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350356-on-u-s-concrete-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on U.S. Concrete Q1 results</a></h4><ul><li>U.S. Concrete (<a href='https://seekingalpha.com/symbol/USCR' title='US Concrete Inc.'>USCR</a> <font color='green'>+1.4%</font>) revenue grew 9.6% Y/Y to $327.8M.</li><li>Aggregate products segment: Revenue +83.3% Y/Y to $32.7M, Adj. EBITDA&nbsp;<font color='red'>margin declined 703 bps&nbsp;</font>to 15.4%, sales price +14.1% Y/Y to $14.35 per ton and sales volume +71.3% Y/Y to 2.1M tons.</li><li>Ready-mixed concretes segment: Revenue +5% Y/Y to $289.2M, Adj. EBITDA&nbsp;<font color='red'>declined by 90 bps</font>&nbsp;to 14.16%, sales price +2% Y/Y to $136.99 per cubic yard, Q1 sales volume +2.2% Y/Y to 2.1M cubic yard and backlog +4% Y/Y to 8.2M cubic yard.</li><li>Q1 overall margins: Adj. gross&nbsp;<font color='red'>declined by 240 bps</font>&nbsp;to 18.8%, operating&nbsp;<font color='red'>declined by 482 bps</font>&nbsp;to 2.3% and Adj. EBITDA&nbsp;<font color='red'>declined by 275 bps</font>&nbsp;to 11%.</li><li>SG&amp;A +20% Y/Y to $32.27M due to costs related to acquisition.</li><li>Net Debt was $719.1M end of Q1, a $48.4M increase due to deployment of capital for the continued acquisition strategy and capital expenditures for plant equipment to support the growing demands.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3350122-us-concrete-misses-0_38-beats-revenue\" target=\"_blank\">US Concrete misses by $0.38, beats on revenue</a> (April 30)</li></ul><div class=\"tiny-share-widget\" data-id=\"3350356\" data-linked=\"More on U.S. Concrete Q1 results\" data-tweet=\"$USCR - More on U.S. Concrete Q1 results https://seekingalpha.com/news/3350356-on-u-s-concrete-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3350356-on-u-s-concrete-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:23 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350360\" data-ts=\"1525108845\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWTR\" target=\"_blank\">TWTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350360-twitter-confirms-selling-data-to-cambridge-academic-shares-move-up\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Twitter confirms selling data to Cambridge academic; shares move up</a></h4><ul>   <li>Twitter's (NYSE:<a href='https://seekingalpha.com/symbol/TWTR' title='Twitter, Inc.'>TWTR</a>) heading in the opposite direction from the market, mitigating opening declines to move <font color='green'>up 1.9%</font> even as the company confirmed it sold data access to the same Cambridge academic who obtained Facebook user data.</li>    <li>Global Science Research and Aleksandr Kogan got access to public data (including months of posts) for a day in 2015. But Twitter says it didn't find access to private data on Twitter users.</li>    <li>And Twitter CEO Jack Dorsey has noted \"We're different from our peers because all of our data is public.\"</li>    <li>Shares have largely ridden out Facebook's Cambridge Analytica scandal, moving <font color='green'>up 20.8%</font> YTD and <font color='green'>up 74.6%</font> over the past 12 months.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3350360\" data-linked=\"Twitter confirms selling data to Cambridge academic; shares move up\" data-tweet=\"$TWTR - Twitter confirms selling data to Cambridge academic; shares move up https://seekingalpha.com/news/3350360-twitter-confirms-selling-data-to-cambridge-academic-shares-move-up?source=tweet\" data-url=\"https://seekingalpha.com/news/3350360-twitter-confirms-selling-data-to-cambridge-academic-shares-move-up\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350353\" data-ts=\"1525108164\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FNGN\" target=\"_blank\">FNGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350353-financial-engines-to-be-bought-hellman-friedman-in-3b-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financial Engines to be bought by Hellman &amp; Friedman in $3B deal</a></h4><ul><li>Financial Engines Inc. (<a href='https://seekingalpha.com/symbol/FNGN' title='Financial Engines, Inc.'>FNGN</a> <font color='green'>+31.7%</font>) soars after <a href=\"https://seekingalpha.com/pr/17145521-financial-engines-announces-agreement-acquired-hellman-and-friedman-45_00-per-share-cash\" target=\"_blank\">agreeing to be acquired</a> by P-E firm Hellman &amp; Friedman for $45/share in cash, a ~32% premium to Friday's closing price of $33.95, in a deal that values FNGN at $3.02B.</li><li>Edelman Financial Services, one of the largest independent financial planning firms in       the U.S. and majority owned by Hellman &amp; Friedman, would be combined with Financial Engines as part of the deal.</li></ul><div class=\"tiny-share-widget\" data-id=\"3350353\" data-linked=\"Financial Engines to be bought by Hellman &amp; Friedman in $3B deal\" data-tweet=\"$FNGN - Financial Engines to be bought by Hellman &amp; Friedman in $3B deal https://seekingalpha.com/news/3350353-financial-engines-to-be-bought-hellman-friedman-in-3b-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3350353-financial-engines-to-be-bought-hellman-friedman-in-3b-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:09 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350352\" data-ts=\"1525108116\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EDIT\" target=\"_blank\">EDIT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350352-crispr-cas9-gene-editors-in-negative-territory-appellate-level-patent-dispute-begins\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CRISPR/Cas9 gene editors in negative territory as appellate-level patent dispute begins</a></h4><ul><li>Editas Medicine (<a href='https://seekingalpha.com/symbol/EDIT' title='Editas Medicine'>EDIT</a> <font color='red'>-2.7%</font>), Intellia Therapeutics (<a href='https://seekingalpha.com/symbol/NTLA' title='Intellia Therapeutics'>NTLA</a> <font color='red'>-1%</font>) and CRISPR Therapeutics (<a href='https://seekingalpha.com/symbol/CRSP' title='CRISPR Therapeutics'>CRSP</a> <font color='red'>-2.9%</font>) are all in the red as <a href=\"https://www.biospace.com/article/crispr-patent-dispute-heats-up-again-today-in-u-s-court-of-appeal/?utm_source=dlvr.it&amp;utm_medium=twitter\" target=\"_blank\">arguments get underway</a> in the U.S. Court of Appeals in the long-running dispute over ownership of the CRISPR/Cas9 gene editing technology.</li><li>Attorneys representing the University of California-Berkeley and the Broad Institute of Technology in Boston are squaring off in an attempt to bring closure to precisely who owns what, a lucrative outcome for the winner.</li><li>UC-Berkeley's Jennifer Doudna and French collaborator Emmanuelle Charpentier were the first to file their patent application but Broad's Feng Zhang out-maneuvered them when he filed for accelerated review of his application filed later by paying a $40 fee.</li><li><a href=\"http://www.intelliatx.com/crispr-technology/\" target=\"_blank\">CRISPR-Cas9</a>&nbsp;is the \"next big thing\" in biotech because of its unprecedented precision in editing DNA.&nbsp;CRISPR, the acronym for \"clustered, regularly interspaced short palindromic repeats,\" uses RNA to guide the molecular scissors, the Cas9 enzyme, to a specific DNA sequence where it makes a specific cut in the DNA and triggers the cell's DNA repair machinery to address the genetic defect.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3244331-crispr-cas9-fight-far\" target=\"_blank\">CRISPR/Cas9 fight could be far from over</a> (Feb. 17, 2017)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3231169-battle-lines-solidified-fight-crispr-cas9-patents\" target=\"_blank\">Battle lines solidified in fight over CRISPR/Cas9 patents</a> (Dec. 16, 2016)</li></ul><div class=\"tiny-share-widget\" data-id=\"3350352\" data-linked=\"CRISPR/Cas9 gene editors in negative territory as appellate-level patent dispute begins\" data-tweet=\"$EDIT $EDIT $NTLA - CRISPR/Cas9 gene editors in negative territory as appellate-level patent dispute begins https://seekingalpha.com/news/3350352-crispr-cas9-gene-editors-in-negative-territory-appellate-level-patent-dispute-begins?source=tweet\" data-url=\"https://seekingalpha.com/news/3350352-crispr-cas9-gene-editors-in-negative-territory-appellate-level-patent-dispute-begins\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350351\" data-ts=\"1525108031\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EVIO\" target=\"_blank\">EVIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350351-evio-acquires-leaf-detective\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EVIO acquires Leaf Detective</a></h4><ul>     <li>EVIO (<a href='https://seekingalpha.com/symbol/EVIO' title='EVIO, Inc.'>OTCQB:EVIO</a> <font color='green'>+3.4%</font>) has executed an asset purchase agreement to acquire 100% of California-based testing lab, Leaf Detective, LLC.</li>     <li>&ldquo;Leaf Detective holds one of only 28 licenses issued by the Bureau of Cannabis Control to testing facilities. Upon completion of this acquisition, we will upgrade the facility to meet new testing standards and plan to be operational by end of third quarter,&rdquo; said William Waldrop, CEO of EVIO Inc. &ldquo;Our goal is to continue to improve consumer safety and increase shareholder value by capturing additional market share.&rdquo;</li><li><a href=\"https://seekingalpha.com/pr/17145413-evio-inc-expands-california-operations-acquires-100-percent-leaf-detective-llc\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3350351\" data-linked=\"EVIO acquires Leaf Detective\" data-tweet=\"$EVIO - EVIO acquires Leaf Detective https://seekingalpha.com/news/3350351-evio-acquires-leaf-detective?source=tweet\" data-url=\"https://seekingalpha.com/news/3350351-evio-acquires-leaf-detective\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350349\" data-ts=\"1525107864\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CREE\" target=\"_blank\">CREE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350349-hedgeye-sees-100-upside-for-cree-risks-are-managed\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hedgeye sees 100% upside for Cree if risks are managed</a></h4><ul><li>           Hedgeye sees an over 100% upside to Cree (NASDAQ:<a href='https://seekingalpha.com/symbol/CREE' title='Cree, Inc.'>CREE</a>) in the next two to three years if near-term risks are successfully managed. </li><li> Analyst Ami Joseph notes risks in &ldquo;potential SiC looseness&rdquo; and says that the firm knows &ldquo;the stock will not go in a straight line.&rdquo;&nbsp; </li><li>         The analyst says there is upside potential for the lighting business, new tech in power devices driving penetration, and a new CEO. </li><li> Source: Bloomberg First Word. </li><li> Cree shares are&nbsp;<font color='red'>down 1.9%</font>&nbsp;to $37.50.&nbsp;            </li></ul><div class=\"tiny-share-widget\" data-id=\"3350349\" data-linked=\"Hedgeye sees 100% upside for Cree if risks are managed\" data-tweet=\"$CREE - Hedgeye sees 100% upside for Cree if risks are managed https://seekingalpha.com/news/3350349-hedgeye-sees-100-upside-for-cree-risks-are-managed?source=tweet\" data-url=\"https://seekingalpha.com/news/3350349-hedgeye-sees-100-upside-for-cree-risks-are-managed\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350348\" data-ts=\"1525107630\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FNGN\" target=\"_blank\">FNGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350348-financials-top-5-gainers-losers-of-1-00-pm-04-30-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM (04/30/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/FNGN' title='Financial Engines, Inc.'>FNGN</a> <font color='green'>+32%</font>. <a href='https://seekingalpha.com/symbol/KMPR' title='Kemper Corporation'>KMPR</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/DCT' title='DCT Industrial Trust Inc.'>DCT</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/CIFS' title='China Internet Nationwide Financial Services Inc.'>CIFS</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/VCTR' title='Victory Capital Holdings, Inc.'>VCTR</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/MCY' title='Mercury General Corporation'>MCY</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/PJC' title='Piper Jaffray Companies'>PJC</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3350348\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM (04/30/2018)\" data-tweet=\"$FNGN $FNGN $KMPR - Financials - Top 5 Gainers / Losers as of 1:00 PM (04/30/2018) https://seekingalpha.com/news/3350348-financials-top-5-gainers-losers-of-1-00-pm-04-30-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3350348-financials-top-5-gainers-losers-of-1-00-pm-04-30-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350343\" data-ts=\"1525107059\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COMM\" target=\"_blank\">COMM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350343-commscopeminus-2_1-morgan-stanley-heads-to-sidelines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CommScope -2.1% as Morgan Stanley heads to sidelines</a></h4><ul>   <li>CommScope (NASDAQ:<a href='https://seekingalpha.com/symbol/COMM' title='CommScope Holding Company Inc.'>COMM</a>) is <font color='red'>2.1% lower</font> after a Morgan Stanley downgrade to Equal Weight from Overweight, saying top-line beats are not going to be enough until some margin headwinds clear after the first half of the year.</li>    <li>The firm has a price target of $41, just 5.5% above Friday's close.</li>    <li>Morgan Stanley says it would be more likely to go back to Overweight and boost that target if the company's North American business were a bigger part of the mix -- or if cash flow utilization were bigger than expected, or it quickly made commodity pricing adjustments. (h/t Bloomberg)</li>    <li>For now, though, the firm still likes CommScope better than other infrastructure names on its flexibility.</li>    <li>Shares are <font color='green'>up 2.7%</font> in 2018; over the past 12 months, they're <font color='red'>down 8.1%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3350343\" data-linked=\"CommScope -2.1% as Morgan Stanley heads to sidelines\" data-tweet=\"$COMM - CommScope -2.1% as Morgan Stanley heads to sidelines https://seekingalpha.com/news/3350343-commscopeminus-2_1-morgan-stanley-heads-to-sidelines?source=tweet\" data-url=\"https://seekingalpha.com/news/3350343-commscopeminus-2_1-morgan-stanley-heads-to-sidelines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:50 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350342\" data-ts=\"1525106982\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STDY\" target=\"_blank\">STDY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350342-midday-gainers-losers-04-30-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers (04/30/2018)</a></h4><ul>     <li><strong>Gainers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/STDY' title='SteadyMed'>STDY</a> <font color='green'>+78%</font>. <a href='https://seekingalpha.com/symbol/FNGN' title='Financial Engines, Inc.'>FNGN</a> <font color='green'>+32%</font>. <a href='https://seekingalpha.com/symbol/CHEK' title='Check-Cap Ltd.'>CHEK</a> <font color='green'>+31%</font>. <a href='https://seekingalpha.com/symbol/ATOS' title='Atossa Genetics, Inc.'>ATOS</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/HTBX' title='Heat Biologics, Inc.'>HTBX</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/ASNS' title='Arsanis, Inc.'>ASNS</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/FDC' title='First Data Corporation'>FDC</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/ANDV' title='Andeavor'>ANDV</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/IRMD' title='iRadimed Corp.'>IRMD</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/AQ' title='Aquantia Corp.'>AQ</a> <font color='green'>+12%</font>.</li>     <li><strong>Losers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/BNTC' title='Benitec'>BNTC</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/ARNC' title='Arconic Inc'>ARNC</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/KPTI' title='Karyopharm Therapeutics Inc.'>KPTI</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/FRED' title='Fred&#39;s, Inc.'>FRED</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/S' title='Sprint Corporation'>S</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/MTSL' title='MER Telemanagement Solutions Ltd.'>MTSL</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/ANDX' title='Andeavor Logistics LP'>ANDX</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/UAVS' title='AgEagle'>UAVS</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/CTB' title='Cooper Tire & Rubber Co.'>CTB</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/CDXC' title='ChromaDex Inc.'>CDXC</a> <font color='red'>-12%</font>.</li>      &nbsp; </ul><div class=\"tiny-share-widget\" data-id=\"3350342\" data-linked=\"Midday Gainers / Losers (04/30/2018)\" data-tweet=\"$STDY $STDY $FNGN - Midday Gainers / Losers (04/30/2018) https://seekingalpha.com/news/3350342-midday-gainers-losers-04-30-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3350342-midday-gainers-losers-04-30-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350335\" data-ts=\"1525105861\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JCP\" target=\"_blank\">JCP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350335-department-store-stocks-fall-back\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Department store stocks fall back</a></h4><ul> <li>The department store is showing some weakness today even with most companies not due to report earnings for a few weeks.</li> <li>Decliners include J.C. Penney (NYSE:<a href='https://seekingalpha.com/symbol/JCP' title='J.C. Penney Company Inc.'>JCP</a>) <font color='red'>-5.4%</font>, Sears Holdings (SHLD) <font color='red'>-4.3%</font>, Macy's (NYSE:<a href='https://seekingalpha.com/symbol/M' title='Macy&#39;s Inc.'>M</a>) <font color='red'>-2.5%</font>, Nordstrom (NYSE:<a href='https://seekingalpha.com/symbol/JWN' title='Nordstrom Inc.'>JWN</a>) <font color='red'>-0.9%</font> and Dillard's (NYSE:<a href='https://seekingalpha.com/symbol/DDS' title='Dillard&#39;s Inc.'>DDS</a>) <font color='red'>-2.3%</font>.</li> <li>A development that could be slightly swaying the sector was the decision mall retailer Chico's FAS to start selling on Amazon.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3350335\" data-linked=\"Department store stocks fall back\" data-tweet=\"$JCP $JCP $SHLDQ - Department store stocks fall back https://seekingalpha.com/news/3350335-department-store-stocks-fall-back?source=tweet\" data-url=\"https://seekingalpha.com/news/3350335-department-store-stocks-fall-back\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350330\" data-ts=\"1525105080\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPPI\" target=\"_blank\">SPPI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350330-spectrum-pharma-rescinds-poison-pill-provision-reshuffles-board-shares-down-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Spectrum Pharma rescinds poison pill provision, reshuffles board; shares down 4%</a></h4><ul><li>Responding to shareholder feedback, Spectrum Pharmaceuticals (<a href='https://seekingalpha.com/symbol/SPPI' title='Spectrum Pharmaceuticals, Inc.'>SPPI</a> <font color='red'>-3.8%</font>) <a href=\"https://seekingalpha.com/pr/17144934-spectrum-pharmaceuticals-announces-corporate-governance-enhancements-board-changes\" target=\"_blank\">amends its bylaws</a> and shareholder rights plan to establish proxy access rights, institute a majority voting standard and rescind its poison pill provision.</li><li>Concurrently, a new candidate for the board has been nominated, Dr. Bernice Wells, to replace the departing Dr. Rajesh Shrotriya and Dr. Luigi Lenaz, reducing the board to eight members.</li></ul><div class=\"tiny-share-widget\" data-id=\"3350330\" data-linked=\"Spectrum Pharma rescinds poison pill provision, reshuffles board; shares down 4%\" data-tweet=\"$SPPI - Spectrum Pharma rescinds poison pill provision, reshuffles board; shares down 4% https://seekingalpha.com/news/3350330-spectrum-pharma-rescinds-poison-pill-provision-reshuffles-board-shares-down-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3350330-spectrum-pharma-rescinds-poison-pill-provision-reshuffles-board-shares-down-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:18 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350328\" data-ts=\"1525104582\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350328-barclays-thinks-new-iphones-wont-include-headphone-adapter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Barclays thinks new iPhones won&#39;t include headphone adapter</a></h4><ul><li>Barclays thinks the trio of Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) iPhones expected to launch this fall <a href=\"https://www.macrumors.com/2018/04/30/barclays-no-headphone-jack-adapter-2018-iphones/\" target=\"_blank\">won&rsquo;t include</a> a Lightning to 3.5mm Headphone Jack Adapter in the box.</li><li>Analyst Blayne Curtis: &ldquo;We currently model no dongle this year.&rdquo;</li><li>Cirrus Logic (NASDAQ:<a href='https://seekingalpha.com/symbol/CRUS' title='Cirrus Logic, Inc.'>CRUS</a>) would lose out as a supplier of audio components in the adapter. Barclays accordingly lowers its quarterly and yearly revenue guidance for Cirrus by 5%.</li><li>Cirrus Logic shares are up 0.4% to $36.34.</li><li>        Apple shares are up 1.6% to $164.92.&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3350187-cirrus-logic-plus-1_5-percent-analyst-upgrade\" target=\"_blank\">Cirrus Logic +1.5% on analyst upgrade</a> (April 30)</li></ul><div class=\"tiny-share-widget\" data-id=\"3350328\" data-linked=\"Barclays thinks new iPhones won&#39;t include headphone adapter\" data-tweet=\"$AAPL $AAPL $CRUS - Barclays thinks new iPhones won&#39;t include headphone adapter https://seekingalpha.com/news/3350328-barclays-thinks-new-iphones-wont-include-headphone-adapter?source=tweet\" data-url=\"https://seekingalpha.com/news/3350328-barclays-thinks-new-iphones-wont-include-headphone-adapter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350318\" data-ts=\"1525104379\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GVA\" target=\"_blank\">GVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350318-granite-construction-up-3-post-q1-results-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Granite Construction up 3% post Q1 results beat</a></h4><ul><li>Granite Construction (<a href='https://seekingalpha.com/symbol/GVA' title='Granite Construction, Inc.'>GVA</a> <font color='green'>+3%</font>) reported Q1 revenue growth of 20.3% Y/Y to $563.4M. Segment Revenues: Construction revenue +18.7% Y/Y to $269.2M, Large project construction +20% Y/Y to $248.4M and construction materials +32.5% Y/Y to $45.7M.</li><li>Q1 overall Gross Margin&nbsp;<font color='green'>improved by 450 bps&nbsp;</font>to 10%. Segment gross margins: Construction<font color='green'> improved by 230 bps</font>&nbsp;to 14.3%, large project construction&nbsp;<font color='green'>improved by 700 bps</font>&nbsp;to 8.2% and construction materials&nbsp;<font color='green'>recovered 840 bps&nbsp;</font>to -5.4%.</li><li>Q1 overall operating margin&nbsp;<font color='green'>recovered by 550 bps</font>&nbsp;to -2.28% and Adj. EBITDA margin&nbsp;<font color='green'>recovered 591 bps&nbsp;</font>to 1.65%.</li><li>Total backlog was at $3.59B (+4.4% Y/Y), Construction -16.8% Y/Y to $978.5M and large project construction +15.4% Y/Y to $2.61B.</li><li>2018 Guidance: Revenue &ndash; low double digit consolidated growth; consolidated EBITDA margin - 7-8%.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3350140-granite-construction-beats-0_17-beats-revenue\" target=\"_blank\">Granite Construction beats by $0.17, beats on revenue</a> (April 30)</li></ul><div class=\"tiny-share-widget\" data-id=\"3350318\" data-linked=\"Granite Construction up 3% post Q1 results beat\" data-tweet=\"$GVA - Granite Construction up 3% post Q1 results beat https://seekingalpha.com/news/3350318-granite-construction-up-3-post-q1-results-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3350318-granite-construction-up-3-post-q1-results-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:06 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350321\" data-ts=\"1525104160\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CNAT\" target=\"_blank\">CNAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350321-conatus-completes-enrollment-in-mid-stage-study-of-emricasan-in-nash-cirrhosis-shares-ahead-1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Conatus completes enrollment in mid-stage study of emricasan in NASH cirrhosis; shares ahead 1%</a></h4><ul><li>Conatus Pharmaceuticals (<a href='https://seekingalpha.com/symbol/CNAT' title='Conatus Pharmaceuticals'>CNAT</a> <font color='green'>+1.2%</font>) is up on below-average volume on the heels of its <a href=\"https://seekingalpha.com/pr/17145031-conatus-announces-completion-enrollment-encore-ph-phase-2b-clinical-trial-emricasan-patients\" target=\"_blank\">announcement </a>that it has completed enrollment in its Phase 2b <a href=\"https://clinicaltrials.gov/ct2/show/NCT02960204?titles=emricasan&amp;spons=conatus&amp;phase=1&amp;rank=3\" target=\"_blank\">ENCORE-PH</a> study assessing emricasan in patients with NASH cirrhosis and severe portal hypertension.</li><li>The primary endpoint is the mean change from baseline to week 24 in a measure of portal vein hypertension called hepatic venous pressure gradient &#40;HVPG&#41;.</li><li>Topline data should be available in Q4.</li><li>Data from two other studies, ENCORE-NF (NASH fibrosis) and ENCORE-LF (decompensated NASH cirrhosis) are expected in H1 2019 and H2 2019, respectively.</li></ul><div class=\"tiny-share-widget\" data-id=\"3350321\" data-linked=\"Conatus completes enrollment in mid-stage study of emricasan in NASH cirrhosis; shares ahead 1%\" data-tweet=\"$CNAT - Conatus completes enrollment in mid-stage study of emricasan in NASH cirrhosis; shares ahead 1% https://seekingalpha.com/news/3350321-conatus-completes-enrollment-in-mid-stage-study-of-emricasan-in-nash-cirrhosis-shares-ahead-1?source=tweet\" data-url=\"https://seekingalpha.com/news/3350321-conatus-completes-enrollment-in-mid-stage-study-of-emricasan-in-nash-cirrhosis-shares-ahead-1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350324\" data-ts=\"1525104056\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRPL\" target=\"_blank\">PRPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350324-consumer-top-gainers-losers-of-12-00-pm-04-30-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 PM (04/30/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/PRPL' title='Purple Innovation, Inc.'>PRPL</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/WPP' title='WPP Plc'>WPP</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/RCKY' title='Rocky Brands, Inc.'>RCKY</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CTB' title='Cooper Tire & Rubber Co.'>CTB</a> <font color='red'>-13%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3350324\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 PM (04/30/2018)\" data-tweet=\"$PRPL $PRPL $WPP - Consumer - Top Gainers / Losers as of 12:00 PM (04/30/2018) https://seekingalpha.com/news/3350324-consumer-top-gainers-losers-of-12-00-pm-04-30-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3350324-consumer-top-gainers-losers-of-12-00-pm-04-30-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350322\" data-ts=\"1525103898\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GALXF\" target=\"_blank\">GALXF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350322-galaxy-resources-hires-j-p-morgan-to-advise-on-argentina-lithium-options\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Galaxy Resources hires J.P. Morgan to advise on Argentina lithium options</a></h4><ul>     <li>Australian lithium miner Galaxy Resources (<a href='https://seekingalpha.com/symbol/GALXF' title='GALAXY RESOURCES ORD NEW'>OTCPK:GALXF</a> <font color='green'>+5.3%</font>) says it has hired J.P. Morgan to <a href=\"https://www.reuters.com/article/us-australia-lithium-galaxy/galaxy-hires-jp-morgan-to-advise-on-argentina-lithium-mine-options-idUSKBN1I10EO\" target=\"_blank\">evaluate strategic options</a> for its Sal de Vida lithium and potash project in Argentina.</li>     <li>Galaxy is seeking to offload its stake in the large and high quality deposit to Chinese or Korean interests, according to reports.</li>     <li>Galaxy says Sal de Vida has the potential to generate total annual revenues of ~$354M, scaling up to 25K metric tons/year of lithium carbonate and 95K metric tons/year of potassium chloride.</li></ul><div class=\"tiny-share-widget\" data-id=\"3350322\" data-linked=\"Galaxy Resources hires J.P. Morgan to advise on Argentina lithium options\" data-tweet=\"$GALXF - Galaxy Resources hires J.P. Morgan to advise on Argentina lithium options https://seekingalpha.com/news/3350322-galaxy-resources-hires-j-p-morgan-to-advise-on-argentina-lithium-options?source=tweet\" data-url=\"https://seekingalpha.com/news/3350322-galaxy-resources-hires-j-p-morgan-to-advise-on-argentina-lithium-options\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350319\" data-ts=\"1525103212\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PBI\" target=\"_blank\">PBI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350319-pitney-bowes-sells-global-production-mail-business\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pitney Bowes sells global production mail business</a></h4><ul> <li>Pitney Bowes (<a href='https://seekingalpha.com/symbol/PBI' title='Pitney Bowes Inc.'>PBI</a> <font color='red'>-2.9%</font>) announces that&nbsp;it sold its document messaging technologies production mail business and supporting software for $361M.</li><li>The company anticipates proceeds from       the sale of approximately $270M, net of estimated closing costs,       transaction fees and taxes.</li><li>Pitney Bowes expects to use the majority of       the proceeds from the sale to pay down debt.</li>     <li>The transaction is expected to close in Q2 or the early part of Q3.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17145452-platinum-equity-acquire-pitney-bowes-global-production-mail-business\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3350319\" data-linked=\"Pitney Bowes sells global production mail business\" data-tweet=\"$PBI - Pitney Bowes sells global production mail business https://seekingalpha.com/news/3350319-pitney-bowes-sells-global-production-mail-business?source=tweet\" data-url=\"https://seekingalpha.com/news/3350319-pitney-bowes-sells-global-production-mail-business\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350313\" data-ts=\"1525102123\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KPTI\" target=\"_blank\">KPTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350313-karyopharm-down-17-ahead-of-mid-stage-selinexor-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Karyopharm down 17% ahead of mid-stage selinexor data</a></h4><ul><li>Karyopharm Therapeutics (<a href='https://seekingalpha.com/symbol/KPTI' title='Karyopharm Therapeutics Inc.'>KPTI</a> <font color='red'>-17.1%</font>) slumps on 35% higher volume ahead the company's expected release of results from a Phase 2 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT02336815?titles=storm&amp;spons=karyopharm&amp;rank=1\" target=\"_blank\">STORM</a>, assessing lead candidate selinexor in treatment-resistant multiple myeloma &#40;MM&#41;, a Fast Track indication.</li><li>Longs may want to put a hedge on.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3207052-karyopharms-selinexor-shows-similar-efficacy-darzalex-treatment-resistant-multiple-myeloma\" target=\"_blank\">Karyopharm's selinexor shows similar efficacy to Darzalex in treatment-resistant multiple myeloma; FDA filing projected in 2018; shares off 6% premarket</a> (Sept. 6, 2016)</li></ul><div class=\"tiny-share-widget\" data-id=\"3350313\" data-linked=\"Karyopharm down 17% ahead of mid-stage selinexor data\" data-tweet=\"$KPTI - Karyopharm down 17% ahead of mid-stage selinexor data https://seekingalpha.com/news/3350313-karyopharm-down-17-ahead-of-mid-stage-selinexor-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3350313-karyopharm-down-17-ahead-of-mid-stage-selinexor-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350303\" data-ts=\"1525102094\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DSPG\" target=\"_blank\">DSPG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350303-dsp-group-up-2_6-post-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DSP Group up 2.6% post Q1 results</a></h4><ul><li>DSP Group (<a href='https://seekingalpha.com/symbol/DSPG' title='DSP Group, Inc.'>DSPG</a> <font color='green'>+2.6%</font>) <a href=\"https://seekingalpha.com/filing/3994473\" target=\"_blank\">reports Q1</a> revenue of $28.11M (+0.6% Y/Y), Segment sales: New products of $14.1M (+26% Y/Y); Office/VoIP of $8.4M (+27% Y/Y); SmartVoice of $1.6M (+316% Y/Y) &amp; SmartHome of $4.1M (-2% Y/Y).</li><li>Improved mix of innovative, differentiated products coupled with operational efficiencies drove adj. gross margin improvement of&nbsp;<font color='green'>490 bps</font>&nbsp;to 49.1% &amp; GAAP operating margin up&nbsp;<font color='green'>365 bps</font>&nbsp;to&nbsp;-8.5%.</li><li>Adj. net income of $0.2M (+118.2% Y/Y) &amp; cash &amp; equivalents of $15.6M (-26.8% Y/Y).</li><li>Company repurchased 0.98M shares in Q1 for ~$1.2M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3350154-dsp-group-beats-0_03-beats-revenue\" target=\"_blank\">DSP Group beats by $0.03, beats on revenue</a> (April 30)</li></ul><div class=\"tiny-share-widget\" data-id=\"3350303\" data-linked=\"DSP Group up 2.6% post Q1 results\" data-tweet=\"$DSPG - DSP Group up 2.6% post Q1 results https://seekingalpha.com/news/3350303-dsp-group-up-2_6-post-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3350303-dsp-group-up-2_6-post-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:28 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350306\" data-ts=\"1525101326\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEUM\" target=\"_blank\">TEUM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350306-pareteumplus-4-on-6m-service-deal-in-asia\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pareteum +4% on $6M service deal in Asia</a></h4><ul>   <li>Pareteum (<a href=\"http://seekingalpha.com/symbol/TEUM\" target=\"_blank\">TEUM</a> <font color='green'>+4%</font>) has ticked up again, this time on a bigger-than-usual win: a <a href=\"https://seekingalpha.com/pr/17145345-pareteum-awarded-6-million-global-cloud-agreement-supporting-internet-things-services\" target=\"_blank\">three-year, $6M global cloud deal</a>.</li>    <li>The company has signed a contract for its Global Cloud Services Platform with an established enterprise integrator and managed service provider in Asia/India subcontinent.</li>    <li>As has been typical in the company's deals, it will be paid monthly for each device managed by the platform as well as revenue for wireless connectivity.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3350306\" data-linked=\"Pareteum +4% on $6M service deal in Asia\" data-tweet=\"$TEUM - Pareteum +4% on $6M service deal in Asia https://seekingalpha.com/news/3350306-pareteumplus-4-on-6m-service-deal-in-asia?source=tweet\" data-url=\"https://seekingalpha.com/news/3350306-pareteumplus-4-on-6m-service-deal-in-asia\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350302\" data-ts=\"1525100833\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NWBO\" target=\"_blank\">NWBO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350302-northwest-bio-secures-additional-1m-in-funding-from-ceo-powers-shares-up-6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Northwest Bio secures additional $1M in funding from CEO Powers; shares up 6%</a></h4><ul><li>Northwest Biotherapeutics (<a href='https://seekingalpha.com/symbol/NWBO' title='Northwest Biotherapeutics, Inc.'>OTCQB:NWBO</a> <font color='green'>+5.8%</font>) is up on modestly higher volume in response to its <a href=\"https://seekingalpha.com/pr/17145351-nw-bio-announces-additional-funding\" target=\"_blank\">announcement </a>that CEO Linda Powers has increased her funding in the company by another $1M, representing a total investment of $5.4M this year.</li><li>The loan, bearing 10% interest, is convertible in Series B Preferred Stock at $2.30 per share, consistent with prior funding. Each Series B share is convertible into 10 common shares at $0.23 per share.</li></ul><div class=\"tiny-share-widget\" data-id=\"3350302\" data-linked=\"Northwest Bio secures additional $1M in funding from CEO Powers; shares up 6%\" data-tweet=\"$NWBO - Northwest Bio secures additional $1M in funding from CEO Powers; shares up 6% https://seekingalpha.com/news/3350302-northwest-bio-secures-additional-1m-in-funding-from-ceo-powers-shares-up-6?source=tweet\" data-url=\"https://seekingalpha.com/news/3350302-northwest-bio-secures-additional-1m-in-funding-from-ceo-powers-shares-up-6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350298\" data-ts=\"1525100520\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AQ\" target=\"_blank\">AQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350298-aquantia-rallies-after-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aquantia rallies after earnings</a></h4><ul> <li>Shares of Aquantia (NYSE:<a href='https://seekingalpha.com/symbol/AQ' title='Aquantia Corp.'>AQ</a>) <font color='green'>jump 8%</font> after the company tops sales estimates with its <a href=\"https://seekingalpha.com/pr/17143341-aquantia-announces-first-quarter-2018-results\" target=\"_blank\">Q1 report</a>.</li> <li>Total revenue during the quarter of $28.4M broke down to data center revenue of $16.3M, enterprise infrastructure revenue of $9.5M, access revenue of $2.5M and automotive revenue of $47K.</li> <li>Gross margin fell to 57% of sales vs. 58% a year ago.</li> <li>\"We expect to see a full slate of client connectivity devices announced at Computex in the first week of June,\" notes CEO Faraj Aalaei.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3349488-aquantia-eps-line-beats-revenue\" target=\"_blank\">Aquantia EPS in-line, beats on revenue</a> (April 26)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3350298\" data-linked=\"Aquantia rallies after earnings\" data-tweet=\"$AQ - Aquantia rallies after earnings https://seekingalpha.com/news/3350298-aquantia-rallies-after-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3350298-aquantia-rallies-after-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350297\" data-ts=\"1525100432\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STDY\" target=\"_blank\">STDY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350297-healthcare-top-5-gainers-losers-of-11-00-04-30-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 AM (04/30/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/STDY' title='SteadyMed'>STDY</a> <font color='green'>+77%</font>. <a href='https://seekingalpha.com/symbol/CHEK' title='Check-Cap Ltd.'>CHEK</a> <font color='green'>+29%</font>. <a href='https://seekingalpha.com/symbol/ATOS' title='Atossa Genetics, Inc.'>ATOS</a> <font color='green'>+22%</font>. <a href='https://seekingalpha.com/symbol/NSPR' title='InspireMD, Inc.'>NSPR</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/ASNS' title='Arsanis, Inc.'>ASNS</a> <font color='green'>+15%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/BNTC' title='Benitec'>BNTC</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/KPTI' title='Karyopharm Therapeutics Inc.'>KPTI</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/SIEN' title='Sientra'>SIEN</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/AQB' title='AquaBounty Technologies, Inc.'>AQB</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/OGEN' title='Oragenics, Inc.'>OGEN</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3350297\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 AM (04/30/2018)\" data-tweet=\"$STDY $STDY $CHEK - Healthcare - Top 5 Gainers / Losers as of 11:00 AM (04/30/2018) https://seekingalpha.com/news/3350297-healthcare-top-5-gainers-losers-of-11-00-04-30-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3350297-healthcare-top-5-gainers-losers-of-11-00-04-30-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350294\" data-ts=\"1525100263\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WETF\" target=\"_blank\">WETF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350294-wisdomtrees-big-run-continues-after-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WisdomTree&#39;s big run continues after upgrade</a></h4><ul><li>KBW's Robert Lee is a believer, upgrading WisdomTree (NASDAQ:<a href='https://seekingalpha.com/symbol/WETF' title='WisdomTree Investments, Inc.'>WETF</a>) to Outperform from Market Perform.</li><li>The company is not just about currency-hedged strategies, says Lee, noting \"healthy and diverse\" inflows of about $1.35B in Q1, and $300M so far this quarter (when excluding flows to the company's currency-hedged Europe and Japan funds).</li><li>His one-year price target of $12.50 suggests&nbsp;<font color='green'>nearly 20% upside</font>&nbsp;from Friday's close. Shares are<font color='green'> up 5.3%</font>&nbsp;today to $10.90, and now&nbsp;<font color='green'>up more than 20%</font>&nbsp;for April.</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3350294\" data-linked=\"WisdomTree&#39;s big run continues after upgrade\" data-tweet=\"$WETF - WisdomTree&#39;s big run continues after upgrade https://seekingalpha.com/news/3350294-wisdomtrees-big-run-continues-after-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3350294-wisdomtrees-big-run-continues-after-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:57 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350283\" data-ts=\"1525100017\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AWI\" target=\"_blank\">AWI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350283-on-armstrong-worlds-q1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Armstrong World&#39;s Q1</a></h4><ul><li>Armstrong World Industries (<a href='https://seekingalpha.com/symbol/AWI' title='Armstrong World Industries, Inc.'>AWI</a> <font color='green'>+0.4%</font>)&nbsp;reported Q1 sales increase of 3.4% Y/Y to $227.3M. Segment sales: Architectural specialty +22% Y/Y to $36.6M and mineral fiber +0.5% Y/Y to $190.7M.</li><li>Q1 overall Margins:  operating margin&nbsp;<font color='red'>declined by 425 bps</font>&nbsp;to 21.8% and Adj. EBITDA&nbsp;<font color='green'>improved by 63 bps</font>&nbsp;to 34.7%.</li><li>Segment margins: Mineral fiber operating&nbsp;<font color='red'>declined by 633 bps</font>&nbsp;to 22.9% and Adj. EBITDA&nbsp;<font color='red'>declined by17 bps</font>&nbsp;to 36.7%; Architectural specialty operating<font color='green'> improved by 668 bps</font>&nbsp;to 22.7% and Adj. EBITDA&nbsp;<font color='green'>improved by 792 bps</font>&nbsp;to 24.6%.</li><li>Company repurchased 1.2M shares in Q1 for ~$70M.</li><li>2018 Guidance reaffirmed: Revenue growth 5-7%; Adj. EBITDA +10%; FCF growth 20-30%; raised EPS $3.60-3.82 due to share repurchase.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3350166-armstrong-world-misses-0_02-misses-revenue\" target=\"_blank\">Armstrong World misses by $0.02, misses on revenue</a> (April 30)</li></ul><div class=\"tiny-share-widget\" data-id=\"3350283\" data-linked=\"More on Armstrong World&#39;s Q1\" data-tweet=\"$AWI - More on Armstrong World&#39;s Q1 https://seekingalpha.com/news/3350283-on-armstrong-worlds-q1?source=tweet\" data-url=\"https://seekingalpha.com/news/3350283-on-armstrong-worlds-q1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:53 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350289\" data-ts=\"1525099883\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMG\" target=\"_blank\">AMG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350289-affiliated-managers-tops-estimates-sees-net-outflows-in-q1-shares-edge-lower\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Affiliated Managers tops estimates, but sees net outflows in Q1; shares edge lower</a></h4><ul><li>Q1 economic net income of $215.2M or $3.92 per share vs. $183.2M and $3.21 a year ago. Adjusted EBITDA of $286.5M vs. $243.8M.</li><li>Net client flows however, were a negative $1.9B, with end-of-quarter AUM of $831B. Company notes equity outflows from institutional clients were more than inflows across alternative strategies.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3350185-affiliated-managers-beats-0_03-beats-revenue\" target=\"_blank\">Affiliated Managers beats by $0.03, beats on revenue</a> (April 30)</li><li><a href='https://seekingalpha.com/symbol/AMG' title='Affiliated Managers Group'>AMG</a>&nbsp;<font color='red'>-0.5%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3350289\" data-linked=\"Affiliated Managers tops estimates, but sees net outflows in Q1; shares edge lower\" data-tweet=\"$AMG - Affiliated Managers tops estimates, but sees net outflows in Q1; shares edge lower https://seekingalpha.com/news/3350289-affiliated-managers-tops-estimates-sees-net-outflows-in-q1-shares-edge-lower?source=tweet\" data-url=\"https://seekingalpha.com/news/3350289-affiliated-managers-tops-estimates-sees-net-outflows-in-q1-shares-edge-lower\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350288\" data-ts=\"1525099612\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NSPR\" target=\"_blank\">NSPR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350288-inspiremds-cguard-and-mguard-okd-in-vietnam-shares-up-17\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">InspireMD&#39;s CGuard and MGuard OK&#39;d in Vietnam; shares up 17%</a></h4><ul><li>InspireMD (<a href='https://seekingalpha.com/symbol/NSPR' title='InspireMD, Inc.'>NSPR</a> <font color='green'>+16.7%</font>) is up on below-average volume in response to its <a href=\"https://seekingalpha.com/pr/17145052-inspiremd-announces-regulatory-approval-reimbursement-commercialize-cguard-eps-mguard-prime\" target=\"_blank\">announcement </a>that its CGuard Embolic Prevention System and MGuard Prime have been approved for sale in Vietnam.</li></ul><div class=\"tiny-share-widget\" data-id=\"3350288\" data-linked=\"InspireMD&#39;s CGuard and MGuard OK&#39;d in Vietnam; shares up 17%\" data-tweet=\"$NSPR - InspireMD&#39;s CGuard and MGuard OK&#39;d in Vietnam; shares up 17% https://seekingalpha.com/news/3350288-inspiremds-cguard-and-mguard-okd-in-vietnam-shares-up-17?source=tweet\" data-url=\"https://seekingalpha.com/news/3350288-inspiremds-cguard-and-mguard-okd-in-vietnam-shares-up-17\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:46 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350274\" data-ts=\"1525099563\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AHGP\" target=\"_blank\">AHGP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350274-alliance-holdings-up-4_8-post-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alliance Holdings up 4.8% post Q1 results</a></h4><ul><li>Alliance Holdings (<a href='https://seekingalpha.com/symbol/AHGP' title='Alliance Holdings GP, L.P.'>AHGP</a> <font color='green'>+4.8%</font>) <a href=\"https://seekingalpha.com/filing/3994474\" target=\"_blank\">reports Q1</a> revenue of $457.04M (-0.9% Y/Y) where Coal sales reduced by 3.4% Y/Y to $423.6M; Transportation revenues was $19.8M (+103% Y/Y) &amp; operating revenues of $13.6M (+7.1% Y/Y).</li><li>Operating margin rose by&nbsp;<font color='green'>1159 bps</font>&nbsp;to 35% &amp; net income jumped 88.5% Y/Y to $103.7M.</li><li>Increases quarterly distribution by 0.7% Y/Y to $0.7475 per share &amp; cash &amp; equivalent was up 257% Q/Q to $30.7M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3350152-alliance-holdings-reports-q1-results\" target=\"_blank\">Alliance Holdings reports Q1 results</a> (April 30)</li></ul><div class=\"tiny-share-widget\" data-id=\"3350274\" data-linked=\"Alliance Holdings up 4.8% post Q1 results\" data-tweet=\"$AHGP - Alliance Holdings up 4.8% post Q1 results https://seekingalpha.com/news/3350274-alliance-holdings-up-4_8-post-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3350274-alliance-holdings-up-4_8-post-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350284\" data-ts=\"1525099031\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARLP\" target=\"_blank\">ARLP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350284-alliance-resource-partnersplus-7-after-easy-q1-beat-higher-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alliance Resource Partners +7% after easy Q1 beat, higher guidance</a></h4><ul>     <li>Alliance Resource Partners (<a href='https://seekingalpha.com/symbol/ARLP' title='Alliance Resource Partners, L.P.'>ARLP</a> <font color='green'>+7%</font>) surges after easily exceeding <a href=\"https://seekingalpha.com/news/3350147-alliance-resource-partners-eps-1_16\" target=\"_blank\">Q1 earnings</a> expectations and raising its full-year revenue guidance above consensus.</li>     <li>ARLP says it now sees FY 2018 revenues of $1.87B-$1.91B from its earlier outlook of $1.78B-$1.82B and above the $1.83B analyst consensus estimate; it also raises guidance for full-year coal production to 41M tons from 40M previously, coal sales volumes to 41.3M tons from 40.3M, revenues to $1.91B from $1.87B, and EBITDA of $730M from $710M previously.</li>     <li>ARLP says weather-related transportation disruptions caused revenues to decline 1% Y/Y to $457M and coal shipments to come in 1.4M tons below expectations for the quarter, but it plans to make up the sales later this year as river conditions return to normal.</li>          <li>The company also <a href=\"https://seekingalpha.com/news/3350047-alliance-resource-partners-declares-0_515-dividend\" target=\"_blank\">raises its quarterly distribution</a> by 1% Q/Q to $0.515/unit.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3350284\" data-linked=\"Alliance Resource Partners +7% after easy Q1 beat, higher guidance\" data-tweet=\"$ARLP - Alliance Resource Partners +7% after easy Q1 beat, higher guidance https://seekingalpha.com/news/3350284-alliance-resource-partnersplus-7-after-easy-q1-beat-higher-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3350284-alliance-resource-partnersplus-7-after-easy-q1-beat-higher-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350282\" data-ts=\"1525098853\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AGN\" target=\"_blank\">AGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350282-allergan-writes-off-lead-candidate-from-640m-vitae-buy-recorded-535m-impairment-charge-in-q1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Allergan writes off lead candidate from $640M Vitae buy, recorded $535M impairment charge in Q1; shares down 2%</a></h4><ul><li>Allergan (<a href='https://seekingalpha.com/symbol/AGN' title='Allergan plc'>AGN</a> <font color='red'>-2.1%</font>) slips on below-average volume in response to its <a href=\"https://seekingalpha.com/pr/17144980-allergan-reports-3-percent-increase-first-quarter-2018-gaap-net-revenues-3_7-billion\" target=\"_blank\">disclosure </a>that it has written off its Phase 2 program for psoriasis candidate VTP-43742, acquired via its $640M acquisition of Vitae Pharmaceuticals in 2016, and recorded a $535.1M impairment charge in Q1.</li><li>The termination of the program, due to safety concerns, obliterates most of the value from the deal. In November 2016, another candidate, VTP-385543, failed to demonstrate a treatment benefit in a mid-stage dermatitis study.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3220480-allergan-hits-pothole-vitae-buy-one-two-main-pipeline-candidates-flunks-mid-stage-dermatitis\" target=\"_blank\">Allergan hits a pothole with Vitae buy; one of two main pipeline candidates flunks mid-stage dermatitis study</a> (Nov. 3, 2016)</li></ul><div class=\"tiny-share-widget\" data-id=\"3350282\" data-linked=\"Allergan writes off lead candidate from $640M Vitae buy, recorded $535M impairment charge in Q1; shares down 2%\" data-tweet=\"$AGN - Allergan writes off lead candidate from $640M Vitae buy, recorded $535M impairment charge in Q1; shares down 2% https://seekingalpha.com/news/3350282-allergan-writes-off-lead-candidate-from-640m-vitae-buy-recorded-535m-impairment-charge-in-q1?source=tweet\" data-url=\"https://seekingalpha.com/news/3350282-allergan-writes-off-lead-candidate-from-640m-vitae-buy-recorded-535m-impairment-charge-in-q1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>34&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350279\" data-ts=\"1525097814\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CELG\" target=\"_blank\">CELG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350279-celgene-down-4-on-extended-timeline-for-ozanimod-resubmission-in-u-s\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Celgene down 4% on extended timeline for ozanimod resubmission in U.S.</a></h4><ul><li>Celgene (<a href='https://seekingalpha.com/symbol/CELG' title='Celgene Corporation'>CELG</a> <font color='red'>-3.8%</font>) slips on below-average volume in apparent reaction to a note from Morgan Stanley that it may take the company over a year to refile its U.S. marketing application for multiple sclerosis med ozanimod.</li><li>The company is due to report Q1 results on Friday.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3335046-celgene-7-percent-premarket-ozanimod-fumble\" target=\"_blank\">Celgene down 7% premarket on ozanimod fumble</a> (Feb. 28)</li></ul><div class=\"tiny-share-widget\" data-id=\"3350279\" data-linked=\"Celgene down 4% on extended timeline for ozanimod resubmission in U.S.\" data-tweet=\"$CELG - Celgene down 4% on extended timeline for ozanimod resubmission in U.S. https://seekingalpha.com/news/3350279-celgene-down-4-on-extended-timeline-for-ozanimod-resubmission-in-u-s?source=tweet\" data-url=\"https://seekingalpha.com/news/3350279-celgene-down-4-on-extended-timeline-for-ozanimod-resubmission-in-u-s\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>41&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350277\" data-ts=\"1525097628\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RENN\" target=\"_blank\">RENN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350277-renren-announces-dividend-private-placement-sharesminus-4_7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Renren announces dividend, private placement; shares -4.7%</a></h4><ul><li>           Renren (NYSE:<a href='https://seekingalpha.com/symbol/RENN' title='Renren Inc.'>RENN</a>) <a href=\"https://seekingalpha.com/pr/17144875-renren-announces-cash-dividend-private-placement-adoption-share-repurchase-plan\" target=\"_blank\">announces</a> a cash dividend of $0.4831 to $0.6096 per share or $7.2465 to $9.1440 per ADS. </li><li> The exact dividend amount will be announced June 11 and depends on an announced private placement announced by subsidiary Oak Pacific Investment. </li><li> The private placement is expected to close June 14. </li><li> Renren shares are&nbsp;<font color='red'>down 4.7%</font>&nbsp;to $9.79.&nbsp; </li></ul><div class=\"tiny-share-widget\" data-id=\"3350277\" data-linked=\"Renren announces dividend, private placement; shares -4.7%\" data-tweet=\"$RENN - Renren announces dividend, private placement; shares -4.7% https://seekingalpha.com/news/3350277-renren-announces-dividend-private-placement-sharesminus-4_7?source=tweet\" data-url=\"https://seekingalpha.com/news/3350277-renren-announces-dividend-private-placement-sharesminus-4_7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350276\" data-ts=\"1525097449\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BWP\" target=\"_blank\">BWP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350276-boardwalk-pipeline-partnersplus-11-loews-may-take-company-private\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Boardwalk Pipeline Partners +11% as Loews may take company private</a></h4><ul>     <li>Boardwalk Pipeline Partners (<a href='https://seekingalpha.com/symbol/BWP' title='Boardwalk Pipeline Partners, LP'>BWP</a> <font color='green'>+11.2%</font>) spikes in early trading after CEO Stanley Horton says in the company's earnings conference call that Loews (<a href='https://seekingalpha.com/symbol/L' title='Loews Corporation'>L</a> <font color='green'>+1.3%</font>) may take the company private.</li>     <li>BWP posted <a href=\"https://seekingalpha.com/news/3350116-boardwalk-pipeline-partners-misses-0_01-misses-revenue\" target=\"_blank\">Q1 earnings</a> that fell slightly short of analyst expectations, as revenues fell 8.6% Y/Y, and declared a <a href=\"https://seekingalpha.com/news/3350121-boardwalk-pipeline-partners-declares-0_10-dividend\" target=\"_blank\">$0.10/share distribution</a>.</li>     <li>Q1 EBITDA of $224M, a 9% decrease, and distributable cash flow of $160M was lower than the $176M in the comparable 2017 period.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3350276\" data-linked=\"Boardwalk Pipeline Partners +11% as Loews may take company private\" data-tweet=\"$BWP $BWP $L - Boardwalk Pipeline Partners +11% as Loews may take company private https://seekingalpha.com/news/3350276-boardwalk-pipeline-partnersplus-11-loews-may-take-company-private?source=tweet\" data-url=\"https://seekingalpha.com/news/3350276-boardwalk-pipeline-partnersplus-11-loews-may-take-company-private\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>76&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350275\" data-ts=\"1525097411\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NYT\" target=\"_blank\">NYT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350275-nytplus-4_5-jpmorgan-upgrades-to-overweight\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NYT +4.5% as JPMorgan upgrades to Overweight</a></h4><ul>   <li>The New York Times Co. (NYSE:<a href='https://seekingalpha.com/symbol/NYT' title='New York Times Co.'>NYT</a>) is <font color='green'>up 4.5%</font> premarket after an upgrade to Overweight at JPMorgan, which sees a company accelerating away from a \"declining print business focused on cost-cutting\" toward a digital growth company.</li>    <li>The firm has bumped its price target to $27 from $25, implying 16.4% upside from this morning's higher price.</li>    <li>The stock's <font color='green'>up 20%</font> YTD.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3350275\" data-linked=\"NYT +4.5% as JPMorgan upgrades to Overweight\" data-tweet=\"$NYT - NYT +4.5% as JPMorgan upgrades to Overweight https://seekingalpha.com/news/3350275-nytplus-4_5-jpmorgan-upgrades-to-overweight?source=tweet\" data-url=\"https://seekingalpha.com/news/3350275-nytplus-4_5-jpmorgan-upgrades-to-overweight\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350273\" data-ts=\"1525097306\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PSTI\" target=\"_blank\">PSTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350273-pluristem-up-15-on-fda-clearance-of-plx-r18-for-acute-radiation-exposure\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pluristem up 15% on FDA clearance of PLX-R18 for acute radiation exposure</a></h4><ul><li>Thinly traded micro cap Pluristem Therapeutics (<a href='https://seekingalpha.com/symbol/PSTI' title='Pluristem Therapeutics, Inc.'>PSTI</a> <font color='green'>+14.5%</font>) is up on a 6x surge in volume on the heels of the <a href=\"https://seekingalpha.com/pr/17144970-u-s-fda-clears-pluristem-s-ind-treat-victims-exposed-acute-radiation\" target=\"_blank\">FDA's approval </a>of its IND for cell therapy PLX-R18 for the treatment of acute radiation syndrome.</li><li>The approval, under the agency's animal rule pathway, allows the company to treat people who may have been acutely exposed to high-dose radiation by accident or due to a nuclear attack. Pluristem plans to maintain an emergency stock of PLX-R18 for such use.</li><li>The FDA's animal rule allows regulatory approval of certain drugs and biologics based on animal testing in situations where human testing is not possible or ethical.</li></ul><div class=\"tiny-share-widget\" data-id=\"3350273\" data-linked=\"Pluristem up 15% on FDA clearance of PLX-R18 for acute radiation exposure\" data-tweet=\"$PSTI - Pluristem up 15% on FDA clearance of PLX-R18 for acute radiation exposure https://seekingalpha.com/news/3350273-pluristem-up-15-on-fda-clearance-of-plx-r18-for-acute-radiation-exposure?source=tweet\" data-url=\"https://seekingalpha.com/news/3350273-pluristem-up-15-on-fda-clearance-of-plx-r18-for-acute-radiation-exposure\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350263\" data-ts=\"1525095824\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350263-on-semiconductorminus-1-despite-q1-beats-in-line-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ON Semiconductor -1% despite Q1 beats, in-line revenue</a></h4><ul><li>        ON Semiconductor shares are&nbsp;<font color='red'>down 1%</font>&nbsp;on Q1 results that narrowly beat EPS and revenue estimates. In-line Q2 guidance has revenue from $1.405B to $1.455B (consensus: $1.42B).</li><li>               Key metrics: Gross margin, 37.6%; operating margin, 15.7%; operating cash flow, $226.5M; FCF, $127M.&nbsp;</li><li>                  The earnings call began at 9 AM Eastern with a webcast / replay available <a href=\"http://www.onsemi.com/\" target=\"_blank\">here</a>.    </li><li>               <a href=\"https://seekingalpha.com/pr/17144756-semiconductor-reports-first-quarter-2018-results\" target=\"_blank\">Press release</a>&nbsp; &nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3350093-semiconductor-beats-0_01-beats-revenue\" target=\"_blank\">ON Semiconductor beats by $0.01, beats on revenue</a> (April 29)</li></ul><div class=\"tiny-share-widget\" data-id=\"3350263\" data-linked=\"ON Semiconductor -1% despite Q1 beats, in-line revenue\" data-tweet=\"ON Semiconductor -1% despite Q1 beats, in-line revenue https://seekingalpha.com/news/3350263-on-semiconductorminus-1-despite-q1-beats-in-line-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3350263-on-semiconductorminus-1-despite-q1-beats-in-line-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:43 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350261\" data-ts=\"1525095739\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FIT\" target=\"_blank\">FIT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350261-fitbitplus-6_8-on-health-collaboration-google\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fitbit +6.8% on health collaboration with Google</a></h4><ul>   <li>Fitbit (NYSE:<a href='https://seekingalpha.com/symbol/FIT' title='Fitbit, Inc.'>FIT</a>) is <font color='green'>up 6.8%</font> after an announcement that it's <a href=\"https://seekingalpha.com/pr/17145386-fitbit-google-announce-collaboration-accelerate-innovation-digital-health-wearables\" target=\"_blank\">collaborating with Google</a> (<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet, Inc. Cl C'>GOOG</a> <font color='green'>+0.2%</font>, <a href='https://seekingalpha.com/symbol/GOOGL' title='Alphabet, Inc. Cl A'>GOOGL</a> <font color='green'>+0.3%</font>) on consumer and enterprise digital health solutions.</li>    <li>Fitbit will use the new Cloud Healthcare API from Google to connect user data from wearables with electronic medical records, which could provide a more comprehensive view into patient profiles.</li>    <li>The wearables maker will also leverage its recently acquired Twine Health in the initiative.</li>    <li>It means Fitbit will move to the Google Cloud Platform for future development.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3350261\" data-linked=\"Fitbit +6.8% on health collaboration with Google\" data-tweet=\"$FIT $FIT $GOOG - Fitbit +6.8% on health collaboration with Google https://seekingalpha.com/news/3350261-fitbitplus-6_8-on-health-collaboration-google?source=tweet\" data-url=\"https://seekingalpha.com/news/3350261-fitbitplus-6_8-on-health-collaboration-google\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>110&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3350255\" data-ts=\"1525094852\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/S\" target=\"_blank\">S</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3350255-sprintminus-10-t-mobileminus-2-analysts-fade-merger-approval-chances\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sprint -10%, T-Mobile -2% as analysts fade merger approval chances</a></h4><ul>   <li>Sprint (NYSE:<a href='https://seekingalpha.com/symbol/S' title='Sprint Corporation'>S</a>) is <font color='red'>down 10.2%</font> premarket as its covering analysts quickly turn into oddsmakers weighing what they say are slimmer than certain chances that its <a href=\"https://seekingalpha.com/news/3350089-sprint-t-mobile-officially-announce-merger-26b-deal\" target=\"_blank\">$26B merger with T-Mobile</a> gets approved.</li>    <li>T-Mobile (NASDAQ:<a href='https://seekingalpha.com/symbol/TMUS' title='T-Mobile US, Inc.'>TMUS</a>) is <font color='red'>down 2.1%</font> premarket for its part.</li>    <li>Analyst Craig Moffett gives the deal a 50/50 chance, while BTIG says it has less than a 40% chance of approval in an environment where U.S. regulators may be loath to allow wireless competition to drop to three major firms. The Justice Dept. is already fighting a vertical merger in AT&amp;T and Time Warner, which many say reduces the odds it might go for a horizontal combination.</li>    <li>Cowen argues that the DOJ is likely to challenge this deal as well, while Makor Capital calls the deal \"dead on arrival.\"</li>    <li>Wells Fargo has downgraded Sprint to Market Perform and given it a $6.25 price target (shares closed Friday at $6.50).</li>    <li>Meanwhile, Guggenheim has boosted Sprint to Neutral, and New Street has upgraded it to Buy.</li><li>T-Mobile is set to report earnings after the closing bell tomorrow and hold a <a href=\"https://seekingalpha.com/pr/17145041-t-mobile-host-q1-2018-earnings-call-may-1-2018\" target=\"_blank\">conference call</a> to discuss the report.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3350255\" data-linked=\"Sprint -10%, T-Mobile -2% as analysts fade merger approval chances\" data-tweet=\"$S $S $TMUS - Sprint -10%, T-Mobile -2% as analysts fade merger approval chances https://seekingalpha.com/news/3350255-sprintminus-10-t-mobileminus-2-analysts-fade-merger-approval-chances?source=tweet\" data-url=\"https://seekingalpha.com/news/3350255-sprintminus-10-t-mobileminus-2-analysts-fade-merger-approval-chances\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>88&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}